26.12.2012 Views

Operating instructions to Module 1 control for English-speaking ...

Operating instructions to Module 1 control for English-speaking ...

Operating instructions to Module 1 control for English-speaking ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Operating</strong> <strong>instructions</strong> <strong>to</strong> <strong>Module</strong> 1 <strong>control</strong><br />

<strong>for</strong> <strong>English</strong>-<strong>speaking</strong> students of medical faculty<br />

“GENERAL PRESCRIPTION. GENERAL PHARMACOLOGY. DRUGS ACTING ON<br />

NERVOUS SYSTEM”<br />

Questions, which are subject of study<br />

1. Definition of pharmacology, its place among other medical and biological<br />

sciences. Main sections of pharmacology: theoretical, experimental, and clinical<br />

pharmacology. New directions of pharmacology’s development.<br />

2. Development of science about drugs in Ukraine and in other states. Origin and<br />

becoming of experimental pharmacology (R. Bukhgeym, Е.В. Pelican, M.P. Kravkov).<br />

А.I.Cherkas as the known Ukrainian pharmacologist and <strong>to</strong>xicologist. Contribution of<br />

scientists of Ukraine <strong>to</strong> development of pharmacology Directions of researches of the<br />

scientists of UMSA.<br />

3. Modern investigation methods in pharmacology. Ways of creation of new<br />

medicinal drugs. Pre-clinical and clinical investigations (phases Ι–ΙV). Functions of State<br />

Pharmacological Center of Public health ministry. The law of Ukraine “About medicinal<br />

drugs”.<br />

4. To give concepts: medicinal substance, medicinal drug, medicinal preparation,<br />

medicinal <strong>for</strong>m. The classification of medicinal <strong>for</strong>ms. Rules of prescribing of dosed and<br />

non-dosed medicinal <strong>for</strong>ms. Requirements <strong>to</strong> medicinal <strong>for</strong>ms <strong>for</strong> injections, rules of their<br />

prescribing.<br />

5. Prescription and its structure. Common rules of drugs prescribing. Rules of<br />

prescribing of the drastic, poisonous and narcotic drugs. Pharmacy. Pharmacopeia.<br />

6. Pharmacokinetics, the definition of this concept. Routes of drugs administration,<br />

their comparative characteristics.<br />

7. Pharmacokinetic parameters: period of half-elimination, stationary concentration,<br />

clearance, constant of absorbtion speed. Age peculiarities of drug pharmacokinetics.<br />

8. Absorbtion of medicinal substances, main mechanisms and fac<strong>to</strong>rs affecting this<br />

process. The definition of bioaviability and bioequivalence.<br />

9. Mechanisms of penetration of medicinal substances through biological<br />

membranes (passive diffusion, carrier-mediated facilitated diffusion, active transport,<br />

endocy<strong>to</strong>sis).<br />

10. Transport and distribution of medicinal substances in the organism. Binding <strong>to</strong><br />

plasma proteins. Ana<strong>to</strong>mic barriers (blood-brain barrier, placenta barrier). Fac<strong>to</strong>rs<br />

modifying distribution. Drugs deposition.<br />

11. Biotrans<strong>for</strong>mation. Stages of biotrans<strong>for</strong>mation. Microsomal oxidation, its<br />

induc<strong>to</strong>rs and inhibi<strong>to</strong>rs. The ways of drug excretion.<br />

12. Pharmacodynamics of medicinal drugs. Types of drugs action (main and sideeffects;<br />

direct and indirect action; local, reflexive and resorbtive action; selective, specific<br />

and non-specific action; reversible and irreversible action).<br />

13. Dose and concentration of medicinal substance, the definition of these<br />

concepts. Dependence of pharmacological effect on a dose and concentration of medicinal<br />

substance. Types of doses. The wideness of therapeutic action. Principles of dosage of<br />

medications <strong>to</strong> children and elderly persons.<br />

14. General mechanisms of drug action. Pharmacological recep<strong>to</strong>rs, the agonists,<br />

the antagonists and the agonists-antagonists of recep<strong>to</strong>rs.<br />

15. Dependence of pharmacological effect on drugs properties, fac<strong>to</strong>rs connected<br />

with the organism (pathological state, biological rhythms, gender, age, genetic fac<strong>to</strong>rs),<br />

climate, and anthropogenic fac<strong>to</strong>rs. Features of reaction of child's organism on drugs.<br />

16. Drugs interaction. The characteristics of pharmaceutical, pharmacokinetic and<br />

pharmacodynamic drug interaction.


17. Combined action of medicinal drugs. Synergism (addition, potentiation),<br />

antagonism (physical, chemical, pharmacological). The significance of the phenomena of<br />

synergism and antagonism <strong>for</strong> a clinic.<br />

18. Side-effects of drugs and their types. Toxic action of drugs (overdose).<br />

Ideosyncrasy. Allergic reactios. Tera<strong>to</strong>genous and mutagenous effects, embryo<strong>to</strong>xicity,<br />

fe<strong>to</strong><strong>to</strong>xicity. Cancerogenous action.<br />

19. Phenomena which are occurred after the repeated administrations of drugs:<br />

accumulation (material and functional), <strong>to</strong>lerance, tachyphylaxis, drugs dependence<br />

(physical, psychological).<br />

20. Classification of drugs affecting afferent nervous system. Astringents: Tannin,<br />

Bismuth subnitrate, the grass of st-john's-wort (herba Hyperici), flowers of chamomile (flos<br />

Chammomillae), leaves of Salvia. Mechanism of action. Indications.<br />

21. Covering and absorbing drugs: mucus from starch (mucilago Amyli) mucus from<br />

seeds of flax (semen Lini); activated charcoal (Carbo activatus), synthetic absorbents<br />

(Enterosgelum). Mechanism of action. Indications. Principles of hemo- and enterosorbtion.<br />

22. Local anesthetics: procaine (Novocainum), lidocaine (Lidocainum),<br />

Trimecainum, benzocaine (Anaesthesinum), tetracaine (Dicainum), articaine (Articainum)<br />

and its preparations: ultracaine, bupivacaine. Classification. Mechanism of action.<br />

Comparative characteristics of local anesthetics, choice of preparations <strong>for</strong> different types<br />

of anesthesia. The purpose of combination of local anesthetics with adrenomimetics.<br />

Resorbtive effects of local anesthetics. Side-effects and measures of their prevention and<br />

treatment. Toxicology of cocaine.<br />

23. Classification of drugs stimulating afferent nervous system. Irritants: solution of<br />

ammonia (Sol Ammonii caustici), menthol (Mentholum), mustard seeds (Charta Synapis),<br />

Turpentine oil (Ol. Terebintinae). Mechanism of action. Application. Bitters (tincture of<br />

Absinthium), emetics with reflexive and central action, laxatives (magnesium sulfate,<br />

antraglycosides containing preparations, cas<strong>to</strong>r oil (Ol. Ricini), gutalax, bisacodyl),<br />

expec<strong>to</strong>rants with reflexive action. Common characteristics. Anti-emetic drugs:<br />

me<strong>to</strong>clopramide (cerucal), hyoscine, neuroleptics, antihistamines.<br />

24. The peculiarities of ana<strong>to</strong>my and physiology of au<strong>to</strong>nomic nervous system. The<br />

mechanism of synaptic transmission. Localization of M- and N- cholinorecep<strong>to</strong>rs.<br />

Classification of cholinergic drugs. Pharmacodynamics of M,-N-cholinomimetics: carbachol<br />

(Carbocholinum).<br />

25. Anticholinesterases. Classification. Mechanism of action, pharmacological<br />

effects, indications, side-effects. Comparative description of neostigmine (Proserinum),<br />

galanthamine (Galantamini hydrobromidum), pyridostigmine (Pyridostigmini<br />

bromidum).Poisoning by phospor organic compounds and its treatment. Pharmacology of<br />

cholinesterase re-activa<strong>to</strong>rs (Alloximum, Dipiroximum).<br />

26. M-cholinomimetics: pilocarpine (Pilocarpini hydrocloridum), Aceclidinum.<br />

Pharmacodynamics, indications <strong>to</strong> usage. Toxic action of muscarine. Help at poisonings.<br />

27. N-cholinomimetics: Cyti<strong>to</strong>num, lobeline (Lobelini hydrochloridum). Mechanism of<br />

action, indications <strong>to</strong> usage in clinical practice. Toxic effects of nicotine. Application of Ncholinomimetics<br />

<strong>for</strong> the fight against smoking.<br />

28. M-cholinoblockers: atropine (Atropini sulfas), hyoscine (Scopolamini<br />

hydrobromidum), plathyphylline (Plathyphyllini hydrotartras), extract of Belladonna,<br />

Methacinum, Ipratropium bromide (atrovent), pirenzepine. Pharmacokinetics,<br />

pharmacodynamics and indications <strong>to</strong> usage of atropine. Comparative characteristics of<br />

other preparations, indications and side-effects. Main signs of poisoning by the plants<br />

which contain the M-cholinoblocking substances; treatment of poisoning.<br />

29. N-cholinoblockers. Classification of ganglion blockers: hexamethonium<br />

(Benzohexonium), Pirilenum, Pentaminum, Hygronium. Pharmacokinetrics, mechanism of<br />

2


action, pharmacodynamics. Comparative characteristics. Indications <strong>to</strong> application in a<br />

clinic. Contraindications, side-effects.<br />

30. Myorelaxants: tubocurarine (Tubocurarini chloridum), Pipecuronium bromidum,<br />

Arduanum, Mellictinum, Dythylinum (Lystenon). Classification on the mechanism of action<br />

and on the duration of effect. Pharmacokinetics and pharmacodynamics of tubocurarine.<br />

Comparative characteristics of other preparations. Application. Side-effects. Help in<br />

overdose.<br />

31. Modern in<strong>for</strong>mation about adrenocep<strong>to</strong>rs, their types and localization.<br />

Classification of adrenergic agonists.Pharmacological characteristics of adrenaline<br />

(Adrenalinei hydrochloridum), indications <strong>to</strong> use. Comparative characteristics of<br />

adrenomimetics: noradrenaline (Noradrenalini hydrotartras), ephedrine (Ephedrini<br />

hydrochloridum), phenylephrine (Mesa<strong>to</strong>num), naphazoline (Naphthyzinum),<br />

xylometazoline (halazolin), isoprenaline (Isadrinum), salbutamol, fenoterol (partusisten).<br />

32. Adrenergic antagonists. Classification. Alpha-adrenoblockers: phen<strong>to</strong>lamine<br />

(Phen<strong>to</strong>lamini hydrocloridum), prazosin, doxazozin. Mechanism of action and effects of<br />

beta-adrenoblockers: propranolol (Anaprilinum), talinolol, atenolol, me<strong>to</strong>prolol. Notion<br />

about intrinsic sympathomimetic activity. Sympatholytics: reserpine (Resrpinum),<br />

guanethidine (Octadinum). Mechanism of action, application and side-effects.<br />

33. Common characteristics of general anesthesia (narcosis). His<strong>to</strong>ry of discovering<br />

of general anesthetics. Types of narcosis. Drugs <strong>for</strong> general anesthesia and their<br />

classification. Drugs <strong>for</strong> inhalation narcosis: ether (Aether pro narcosi), isoflurane, nitrous<br />

oxide. Physical and chemical description. Mechanism of action. Wideness of narcosis<br />

action. Comparative characteristics. Side-effects and their prophylaxis.<br />

34. Drugs <strong>for</strong> IV anesthesia. Classification on duration of action. Pharmacological<br />

characteristics of thiopental sodium (Thyopentalum-natrium), ketamine (Ketalar), sodium<br />

oxybutyrate (Natrii oxibutiras), propofol (Propanididum). Combined application of drugs <strong>for</strong><br />

general anesthesia with preparations of another pharmacological groups. Concepts of premedication,<br />

inductive narcosis, basis narcosis, combined narcosis.<br />

35. Alcohol (Spiritus aethylicus). Resorbtive and local action. Usage in a clinic.<br />

Acute poisoning and its treatment. Alcoholism as medical and social problem. Principles of<br />

pharmacological therapy of alcoholism. Mechanism of action of disulfiram (Teturamum).<br />

36. Hypnotics. Physiological role of sleep and normal sleep patterns. Classification<br />

of hypnotics on chemical structure. Phenobarbi<strong>to</strong>ne (Phenobarbitalum), nitrazepam,<br />

Bromizovalum, chloral hydrate, zopiclone, zolpidem. Classification. Pharmacokinetics,<br />

mechanism of action. Comparative characteristics. Usage. Side-effects. Acute poisoning<br />

with barbiturates and principles of its treatment.<br />

37. Narcotic analgesics and their antagonists: morphine (Morphini hydrochloridum),<br />

Omnoponum, codeine (Codeini phosphas), fentanyl (Phentanylum), pentazocine<br />

(Pentazocinum), trimeperidine (Promedolum), tramadol, buprenorphine. Classification.<br />

Pharmacokinetics, pharmacodynamics, comparative characteristics, indications, side–<br />

effects. Acute poisoning with narcotic analgesics and main principles of its treatment. Drug<br />

dependence. Antagonists of narcotic analgesics: nalorphine (Nalorphini hydropchloridum),<br />

naloxone, naltrexone.<br />

38. Non-narcotic analgesics: aspirin (Acidum acetylsalicylicum), metamizol<br />

(Analginum), paracetamol (Acetaminophen), mephenamic acid (Acidum mefenamicum),<br />

ibuprofen, indomethacin, piroxicam, diclophenac (Diclophenac-natrium), meloxicam,<br />

celecoxib, Amizonum. Classification. Pharmacokinetics, pharmacodynamics, comparative<br />

characteristics, application, side-effects.<br />

39. Antiepileptic drugs: phenobarbital (Phenobarbitalum), pheny<strong>to</strong>in (Dipheninum),<br />

carbamazepine (Finlepsinum), clonazepam, ethosuximide, sodium valproate, lamotridgine.<br />

Classification on clinical usage. Pharmacokinetics, pharmacodynamics. Indications. Side-<br />

3


effects. Preparations <strong>for</strong> termination of seizure attack (tranquilizers, myorelaxants,<br />

hypnotics, general anesthetics).<br />

40. Antiparkinsonian drugs: levodopa, nakom, amantadine (Midantanum),<br />

Cyclodolum. Classification. Main mechanisms of action. Clinical use. Drugs <strong>for</strong> treatment<br />

of skeletal muscles hyper<strong>to</strong>ne: benzodiazepins, GABA-ergic drugs, midocalm. Common<br />

description.<br />

41. Neuroleptics: chlorpromazine (Aminazinum), trifluoperazine (Triftazinum),<br />

fluphenazine (Phthorphenazinum), droperidol, haloperidol, clozapine, chloprprothixene,<br />

sulpiride. Classification. Mechanism of action. Pharmacokinetics, pharmacodynamics.<br />

Comparative characteristics. Indications. Side-effects. Notion about neuroleptanalgesia.<br />

42. Tranquilizers: chlordiazepoxide (Chlozepidum), diazepam (Sibazonum),<br />

Phenazepamum, medazepam, gidazepam. Classification. Mechanism of action.<br />

Pharmacokinetics, pharmacodynamics. Indications. Side-effects and their prevention.<br />

Notion about “day-time” tranquilizers and atypical tranquilizers. Ataralgesia.<br />

43. Sedative drugs: sodium bromide (Natrii bromidum), infusion from roots of<br />

valerian, Corvaldinum. Pharmacokinetics of bromides. Pharmacodynamics of sedative<br />

drugs. Indications and side-effects. Notion about bromism, its treatment and prevention.<br />

Lithium preparations: lithium carbonate. Pharmacokinetics, pharmacodynamics,<br />

indications, side-effects. Acute poisoning with lithium salts and its treatment.<br />

44. CNS stimulants. Classification. Psychomo<strong>to</strong>r stimulants:сaffeine (Coffeini-natrii<br />

benzoas), sydnocarb. Pharmacokinetics, pharmacodynamics. Indications and<br />

contraindications. Side-effects. Notion about psychodisleptics and amphetamines, drug<br />

dependence on these agents.<br />

45. Antidepressants: imipramine (Imizinum), amitriptyline, Pirazidolum, fluoxetine.<br />

Classification on mechanism of action and chemical structure. Pharmacokinetics,<br />

pharmacodynamics, comparative characteristics. Side-effects.<br />

46. Nootrops: piracetam (Nootropil), cavin<strong>to</strong>n, sermion (Nicergoline),<br />

pen<strong>to</strong>xyphylline, sodium oxybutyrate (Natrii oxybutiras) Classification. Mechanism of<br />

action. Pharmacological effects. Indications.<br />

47. Adap<strong>to</strong>gens and ac<strong>to</strong>protec<strong>to</strong>rs: extract of Eleutherococcus, tincture of Ginseng,<br />

tincture of Shizandra, Pan<strong>to</strong>crinum, Bemithylum Pharmacodynamics. Comparative<br />

characteristic. Indications.<br />

48. Analeptics: caffeine (Coffeini-natrii benzoas), nikethamide (Cordiaminum),<br />

camphor (Camphora), Sulfacamphocainum, Bemegridum, Aethimizolum, Carbogenum.<br />

Classification on mechanism of action and chemical structure. Pharmacokinetics,<br />

pharmacodynamics. Indications. Side-effects.<br />

49. Antitussives: codeine (Codeini phosphas), oxeladine, libexin, glauvent (Glaucini<br />

hydrochloridum). Mechanism of action. Application. Side-effects.<br />

50. Expec<strong>to</strong>rants: infusion from the grass of Thermopsis, decoction from the root of<br />

Althea, Mucaltinum, trypsin (Trypsinum crystallisatum), Ambroxolum, bromhexine,<br />

acetylcysteine. Classification. Pharmacodynamics. Indications. Side-effects. Stimulants of<br />

surfactant synthesis (Ambroxolum) and their pharmacological characteristics.<br />

Preparations, which are subject of study<br />

Natrii oxybutiras – amp. 20% sol. – 10 ml<br />

Ketaminum –flac.1% sol. –20 ml<br />

Zolpidem – tab. 0,01<br />

Natrii valproas – tab. 0,3<br />

Carbamazepinum – tab.0,2<br />

Nitrazepamum – tab.0,005<br />

Phenobarbitalum – tab.0,1<br />

Levodopa – caps. 0,025<br />

4


Мorphini hydrochloridum – amp. 1% sol. –1 ml<br />

Promedolum – amp. 1% (or 2%) sol. – 1 ml<br />

Tramadolum – tab. 0,05; amp. 5% sol. – 1 ml<br />

Naloxoni hydrochloridum – amp. 0,04 % sol. –1 ml (1ml – 0,0004)<br />

Analginum – tab. 0,5; amp. 50% sol. –2 ml<br />

Acidum acethylsalicylicum – tab. 0,5<br />

Diclofenac-natrium – tab. 0,025; amp. 2,5% sol. – 2 ml<br />

Paracetamolum – tab.0,2; rectal supp. 0,15<br />

Celecoxibum – caps.0.1<br />

Aminazinum – drag. 0,025; amp. 2,5 % sol. –1 ml<br />

Droperidolum – amp. 0,25% sol. –10 ml<br />

Gidazepamum – tab. 0,01<br />

Phenazepamum – tab.0,0005 (or 0,001)<br />

Sibazonum – tab. 0,005; amp. 0,5% sol. – 2 ml<br />

Тіncturа Valerianae – bottles on 30 ml<br />

Coffeini-natriі benzoas – tab. 0,1; amp. 10% sol. – 1 ml<br />

Amitriptylinum – tab. 0,025; amp. 1% sol. – 2 ml<br />

Fluoxetinum – caps. 0,02<br />

Cordіaminum – bottles on 15 ml; amp. on 1 ml<br />

Aethimizolum – amp. 1,5% sol. – 2 ml<br />

Sulfocamphocainum – amp. 10% sol. – 2 ml<br />

Pyracetamum – tab. 0,4; amp. 20% sol. – 5 ml<br />

Novocainum – amp. 2% sol. (or 0,5% sol.) – 5 ml<br />

Lidocainum – amp. 2% sol. (or 10% sol.) – 2 ml<br />

Anaesthesinum – 5% aspersion; 5% ointment; 5% paste, rectal supp. 0,1<br />

Adrenalini hydrochloridum – amp. 0.1% sol. – 1 ml<br />

Noradrenalini hydrotartras – amp. 0,2% sol. – 1 ml<br />

Mesa<strong>to</strong>num – amp. 1% sol. – 1 ml<br />

Isadrinum – tab. 0,005; flac. on 25 ml of 0,5% sol. (<strong>for</strong> inhalation)<br />

Salbutamolum – aerosolum 10 ml<br />

Fenoterolum (Partusisten) – tab.0,005; amp. on 10 ml<br />

Prazosinum – tab.0,001<br />

Anaprilinum – tab.0,01; amp. 0,01 % sol. –1 ml<br />

Me<strong>to</strong>prololum – tab. 0,1 (or 0,05)<br />

Reserpinum – tab. 0,0001<br />

Atropini sulfas – tab. 0,0005; amp. 0,1% sol. – 1 ml; bottles on 5 ml of 1% sol. (eye drops)<br />

Plathyphyllini hydrotartras – amp. 0,2 % sol. – 1 ml<br />

Pirenzepinum – tab. 0,05<br />

Ipratropii bromidum – aerosolum 15 ml<br />

Рilocarpini hydrochloridurn – bottles on 10 ml of 1% sol. (eye drops)<br />

Proserinum – tab.0,015; amp. 0,05% sol. – 1 ml<br />

Galanthamini hydrobromidum – amp. 1 % sol. – 1 ml<br />

Alloximum – amp. on 0,075<br />

Tubocurarini chloridum – amp. 1 % sol. – 1,5 ml<br />

Dithylinum –amp. 2 % sol. – 10 ml<br />

Dimedrolum – tab.0,05; amp. 1% sol. – 1 ml<br />

Loratadinum – tab.0,01<br />

Suprastinum – tab.0,025; amp. 2,5 % sol. – 1 ml<br />

Magnesii sulfas –amp. 25% sol. – 10 ml<br />

Dimedrolum – tab.0,05; amp. 1% sol. – 1 ml<br />

Tanninum – 0,5 and 5% sol.<br />

Sol. Ammonii caustici –amp. on 1 ml or bottles on 30 ml of 10% sol. (<strong>for</strong> external use)<br />

5


Ambroxolum – tab. 0,003; sirupus 100 ml<br />

Mentholum – 1% ointment <strong>for</strong> nose<br />

Apomorphini hydrochloridum – amp. 1% sol. – 1 ml<br />

Theophyllinum – tab.0,3<br />

Acetylcysteinum – tab.0,001<br />

Glaucini hydrochloridum – tab.0,05<br />

Tests<br />

1. Non-liquid dosed medicinal <strong>for</strong>ms are<br />

– Tablets<br />

– Capsules<br />

– Powders <strong>for</strong> internal use<br />

– Powders <strong>for</strong> external use<br />

– Tablets, capsules, and powders <strong>for</strong> internal use<br />

2. Liquid dosed medicinal <strong>for</strong>ms are<br />

– Eye drops<br />

– Liniments<br />

– Drops <strong>for</strong> taking inside<br />

– Solutions <strong>for</strong> taking inside<br />

– Both drops <strong>for</strong> taking inside and solutions <strong>for</strong> taking inside<br />

3. Solid non-dosed medicinal <strong>for</strong>m is only<br />

– Capsules<br />

– Ampoules<br />

– Ointments<br />

– Aspersions<br />

– Eye drops<br />

4. Soft non-dosed medicinal <strong>for</strong>ms are all except<br />

– Liniments<br />

– Pastes<br />

– Ointments<br />

– Gels<br />

– Ampoules<br />

5. Non-dosed medicinal <strong>for</strong>m which must be sterile<br />

– Capsules<br />

– Ampoules<br />

– Ointments<br />

– Aspersions<br />

– Eye drops<br />

6. Soft dosed medicinal <strong>for</strong>m used only in gynecology is<br />

– Solutions<br />

– Rectal supposi<strong>to</strong>ries<br />

– Ointments<br />

– Vaginal supposi<strong>to</strong>ries<br />

– Drops<br />

7. Medicinal <strong>for</strong>ms <strong>for</strong> injections should be<br />

– Sterile<br />

6


– Homogenic<br />

– Apyrogenic<br />

– Iso<strong>to</strong>nic<br />

– Sterile, homogenic and apyrogenic at the same time<br />

8. Liquid <strong>for</strong>ms from medicinal plants are all except<br />

– Infusions<br />

– Decoctions<br />

– Tinctures<br />

– Liquid extracts<br />

– Ointments<br />

9. Weight margins <strong>for</strong> dosed powders are<br />

– 0,1-1,0<br />

– 0,01-0.1<br />

– 0,1-0,5<br />

– 1,0 – 5,0<br />

– 1,0 – 10,0<br />

10. Solutions <strong>for</strong> internal use are prescribed overage on<br />

– 12 administrations<br />

– 5 administrations<br />

– 20 administrations<br />

– 1 administration<br />

– None of above listed<br />

11. Drops <strong>for</strong> internal use are prescribed overage on<br />

– 12 administrations<br />

– 5 - 10 administrations<br />

– 20 - 30 administrations<br />

– 1 administration<br />

– None of above listed<br />

12. Pastes are<br />

– Dense ointments<br />

– Liquid ointments<br />

– Very fine powders<br />

– Water extractions from medicinal plants<br />

– Alcohol extractions from medicinal plants<br />

13. Liniments are<br />

– Dense ointments<br />

– Liquid ointments<br />

– Very fine powders<br />

– Forms <strong>for</strong> injections<br />

– Forms <strong>for</strong> internal use<br />

14. Aspersions always contain<br />

– Inert dry substances<br />

– Distilled water<br />

– Vaseline<br />

– Alcohol<br />

7


– None of listed<br />

15. Contents of dry substances in paste should be<br />

– Less than 25%<br />

– More than 25%<br />

– 25% - 65%<br />

– 65% - 100%<br />

– None of listed<br />

16. Constituens in ointments may be represented by all except<br />

– Glycerin<br />

– Eugenol<br />

– Vaseline oil<br />

– Formalin<br />

– Vaseline<br />

17. Main rules of prescribing are<br />

– In Latin<br />

– By ink or ball pen<br />

– Without corrections<br />

– With physician’s signature and stamp<br />

– All listed<br />

18. Doses of dry substances in prescriptions are indicated in<br />

– Grams<br />

– Milligrams<br />

– Kilograms<br />

– Milliliters<br />

– Liters<br />

19. Doses of liquids in prescriptions are indicated in<br />

– Grams<br />

– Milligrams<br />

– Kilograms<br />

– Milliliters<br />

– Liters<br />

20. Main rules of prescribing of poisons and narcotic drugs are<br />

– Form №1; physician’s signature and stamp at the end of prescription<br />

– Form №2; physician’s signature and stamp at the end of prescription<br />

– Form №3; physician’s signature and stamp at the end of prescription<br />

– Form №3; physician’s signature and stamp of the hospital at the end of prescription<br />

– Form №3; physician’s signature and stamp at the end of prescription + signature of the<br />

head of the clinic and stamp of the hospital<br />

21. Parts of prescription which are written in Latin<br />

– Inscription<br />

– Subscription<br />

– Signature<br />

– Designation of materials<br />

– Designation of material and subscription<br />

8


22. Parts of prescription which are written in the state language<br />

– Inscription<br />

– Subscription<br />

– Signature<br />

– Designation of materials<br />

– Both inscription and signature<br />

23. Absorbtion is:<br />

– Drug’s penetration from the site of administration in<strong>to</strong> the blood<br />

– Drug’s penetration from the blood in<strong>to</strong> tissues<br />

– Chemical trans<strong>for</strong>mation of the drug<br />

– Drugs interaction<br />

– Binding <strong>to</strong> plasma proteins<br />

24. The main reactions of biotrans<strong>for</strong>mation stage I are<br />

– Glycolysis<br />

– Conjugation<br />

– Hydrolysis<br />

– Microsomal oxidation<br />

– Lipid peroxidation<br />

25. Drugs are transported in connection with<br />

– Albumens<br />

– Nucleic acids<br />

– Phospolipids<br />

– Salts ions<br />

– All listed<br />

26. In blood plasma drugs are transported<br />

– In connection with albumens<br />

– In connection with lipoproteins<br />

– In connection with blood cells<br />

– In water fraction<br />

– All listed<br />

27. Drugs are excreted with all liquids except<br />

– Gastric juice<br />

– Urine<br />

– Bile<br />

– Saliva<br />

– Nursing mother’s milk<br />

28. Drug excretion is<br />

– Metabolism of the drug in the body<br />

– Penetration of the drug in<strong>to</strong> the blood from the site of its administration<br />

– Penetration through tissue barriers<br />

– Inactivation of the drug<br />

– Taking out of the drug<br />

29. Drug elimination includes<br />

– Absorbtion and distribution<br />

– Transport and biotrans<strong>for</strong>mation<br />

9


– Penetration through tissue barriers<br />

– Distribution and biotrans<strong>for</strong>mation<br />

– Biotrans<strong>for</strong>mation and excretion<br />

30. Main mechanisms of renal excretion are<br />

– Microsomal oxidation<br />

– Filtration, tubule secretion and reabsorbtion<br />

– Passive diffusion<br />

– Filtration through pores<br />

– All listed<br />

31. Main mechanisms of drugs crossing through cell membrane are<br />

– Active transport<br />

– Endocy<strong>to</strong>sis<br />

– Passive diffusion<br />

– Filtration through pores<br />

– All listed<br />

32. Energy-dependent mechanism of drugs crossing through cell membrane is<br />

– Active transport<br />

– Phagocy<strong>to</strong>sis<br />

– Passive diffusion<br />

– Filtration through pores<br />

– All listed<br />

33. Energy-independent mechanism of drugs crossing through cell membrane is<br />

– Active transport<br />

– Endocy<strong>to</strong>sis<br />

– Passive diffusion<br />

– “Biological pumps”<br />

– All listed<br />

34. Routs of administration suitable <strong>for</strong> emergence help are all except<br />

– Sublingual<br />

– Oral<br />

– By inhalation<br />

– By injection<br />

– Rectal<br />

35. Drugs administered by injections<br />

– Have slow onset of action<br />

– Must be sterile<br />

– Are not suitable <strong>for</strong> emergence help<br />

– Do not need special equipment<br />

– Are not accompanied by trauma and pain<br />

36. Drugs administered orally<br />

– Have slow onset of action<br />

– Must be sterile<br />

– Are suitable <strong>for</strong> emergence help<br />

– Need special equipment<br />

– Accompanied by trauma of skin and pain<br />

10


37. Sublingual administration is characterized by<br />

– Slow onset of action<br />

– Rapid onset of action and absence of first-pass metabolism<br />

– Absorbtion of the drug in the s<strong>to</strong>mach<br />

– Intensive first-pass metabolism in the liver<br />

– Trauma of skin and pain<br />

38. Enteral rout of administration is only<br />

– Oral<br />

– Intranasal<br />

– IV<br />

– SC<br />

– Topical application<br />

39. Pharmacokinetics studies<br />

– Mechanism of action<br />

– Main effects<br />

– Side-effects<br />

– Metabolism of drugs<br />

– Combined action of drugs<br />

40. Pharmacokinetics studies<br />

– Types of doses<br />

– Main effects<br />

– Side-effects<br />

– Effects after repeated drugs administration<br />

– Absorbtion and distribution of drugs<br />

41. Pharmacodynamics studies all except<br />

– Mechanism of action<br />

– Main effects<br />

– Side-effects<br />

– Effects after repeated drugs administration<br />

– Drugs elimination<br />

42. All concerning doses of drugs is correct except<br />

– Single dose is the dose <strong>for</strong> one administration<br />

– Therapeutical dose may be minimal, overage, and maximal<br />

– LD-50 causes the death of 50% of animals in experiments<br />

– Supporting dose is high dose at the start of treatment<br />

– Toxic dose is the amount of drug causing poisoning<br />

43. Local action is<br />

– Action after absorbtion in<strong>to</strong> the blood<br />

– Action in the site of administration<br />

– Action by reflexes<br />

–Short-durative action<br />

– Irreversible action<br />

44. Resorbtive action is<br />

– Action after absorbtion in<strong>to</strong> the blood<br />

11


– Action in the site of administration<br />

– Action by reflexes<br />

– Reversible action<br />

– Irreversible action<br />

45. All concerning drugs action is true except<br />

– Action may be reversible and irreversible<br />

– Reflexive action is due reflexes from the site of drug application<br />

– Local action is the action after absorbtion in<strong>to</strong> the blood<br />

– Direct action is the action on target organ<br />

– Indirect action is the action on organ by influence on another one<br />

46. Tachyphylaxis is<br />

– The <strong>for</strong>m of drug’s accumulation<br />

– The <strong>for</strong>m of biotrans<strong>for</strong>mation<br />

– Rapid <strong>for</strong>m of <strong>to</strong>lerance<br />

– Manifestation of drug dependence<br />

– Combined action of drugs<br />

47. Notions connected with combined action of medications are<br />

– Synergism and antagonism<br />

– Material accumulation<br />

– Drug dependence<br />

– Tolerance and tachyphylaxis<br />

– Elimination and excretion<br />

48. All listed is true except<br />

– Tolerance is the decrease in drug’s action after its repeated administration<br />

– Drugs’ interaction may be pharmaceutical and pharmacological<br />

– Idiosyncrasy is the <strong>for</strong>m of allergy<br />

– Tera<strong>to</strong>geneous action is negative drug’s influence on embrio and fetus<br />

– Cancerogeneous action is drug’s ability <strong>to</strong> initiate malignant tumor<br />

49. Adverse effects are represented by<br />

– Accumulation<br />

– Direct <strong>to</strong>xic action<br />

– Antagonism<br />

– Synergism<br />

– Addition<br />

50. Repeated application of drug may cause all listed except<br />

– Pharmaceutical interaction<br />

– Tolerance<br />

– Physical dependence<br />

– Functional accumulation<br />

– Psychological dependence<br />

51. Pharmacological recep<strong>to</strong>r is<br />

– Protein molecule specifically binding with the drug<br />

– Target cell affected by the drug<br />

– Target organ affected by the drug<br />

– Synaptic structure<br />

12


– None of listed<br />

52. Agonist of pharmacological recep<strong>to</strong>r is<br />

– Drug stimulating recep<strong>to</strong>r<br />

– Drug inhibiting recep<strong>to</strong>r<br />

– Drug stimulating one subtype of recep<strong>to</strong>r and inhibiting another one<br />

– Drug bound <strong>to</strong> recep<strong>to</strong>r<br />

– Drug without affinity <strong>to</strong> recep<strong>to</strong>r<br />

53. Antagonist of pharmacological recep<strong>to</strong>r is<br />

– Drug stimulating recep<strong>to</strong>r<br />

– Drug inhibiting recep<strong>to</strong>r<br />

– Drug stimulating one subtype of recep<strong>to</strong>r and inhibiting another one<br />

– Drug bound <strong>to</strong> recep<strong>to</strong>r<br />

– Drug without affinity <strong>to</strong> recep<strong>to</strong>r<br />

54. Agonist-antagonist of pharmacological recep<strong>to</strong>r is<br />

– Drug stimulating recep<strong>to</strong>r<br />

– Drug inhibiting recep<strong>to</strong>r<br />

– Drug stimulating one subtype of recep<strong>to</strong>r and inhibiting another one<br />

– Drug bound <strong>to</strong> recep<strong>to</strong>r<br />

– Drug without affinity <strong>to</strong> recep<strong>to</strong>r<br />

55. Pharmacological recep<strong>to</strong>rs are located<br />

– On internal surface of cell membrane<br />

– On external surface of cell membrane<br />

– In nucleus<br />

– In cy<strong>to</strong>plasma<br />

– All listed<br />

56. All concerning drugs allergy is true except<br />

– It is side-effect<br />

– It is developed after sensitization<br />

– It may be in the <strong>for</strong>m of anaphylaxis<br />

– It is developed after the first administration of drug<br />

– It is treated by antihistamines<br />

57. All concerning idiosyncrasy is true except<br />

– It is side-effect<br />

– It is genetically determined<br />

– It may be in the <strong>for</strong>m of anaphylaxis<br />

– It is developed after the first administration of drug<br />

– It is occurred in patients with deficit of G-6-PDG treated by antimalarial drugs<br />

58. If one drug exerts effect A and potentiates another drug with effect B, their<br />

common action C may by represented as<br />

– A+B=C<br />

– A+B>C<br />

– A+B


59. If one drug exerts effect A and displays addition <strong>to</strong> another drug with effect B,<br />

their common action C may by represented as<br />

– A+B=C<br />

– A+B>C<br />

– A+BC<br />

– A+BC<br />

– All is not correct<br />

61. Drugs synergism is used<br />

– For potentiation of general anesthesia<br />

– For antidote therapy of poisonings<br />

– For pharmaceutical drugs interaction<br />

– For prophylaxis of drugs side-effects<br />

– All listed<br />

62. Drugs antagonism is used<br />

– For potentiation of general anesthesia<br />

– For antidote therapy of poisonings<br />

– For pharmaceutical drugs interaction<br />

– For prophylaxis of drugs side-effects<br />

– All listed<br />

63. Interaction between tetracycline and calcium salts during the absorbtion is<br />

– Pharmaceutical drugs interaction<br />

– Pharmacokinetic drugs interaction<br />

– Pharmacodynamic drugs interaction<br />

– Physiological antagonism<br />

– Drugs combined action<br />

64. All concerning <strong>to</strong>lerance is true except<br />

– It is a result of repeated drug administration<br />

– It is displayed in decrease of drugs efficacy<br />

– It is displayed in allergic reactions<br />

– It is overcome by increase in dose of drug<br />

– It is due <strong>to</strong> activation of microsomal oxidation<br />

65. Material accumulation is concerning<br />

– Drugs interaction<br />

– Combined action of drugs<br />

– Adverse effects of drugs<br />

– Main effects of drugs<br />

– Repeated administration of drugs<br />

66. Functional accumulation is concerning<br />

14


– Drugs interaction<br />

– Combined action of drugs<br />

– Adverse effects of drugs<br />

– Main effects of drugs<br />

– Repeated administration of neurotropic drugs<br />

67. The drug enters the rest of the body be<strong>for</strong>e first-pass metabolism after<br />

– IV administration<br />

– Oral administration<br />

– Transdermal administration<br />

– Topical application<br />

– None of above listed<br />

68. Anaphylactic shock caused by penicillin G is<br />

– Direct <strong>to</strong>xic effect<br />

– Manifestation of idiosyncrasy<br />

– Allergic reaction<br />

– Manifestation of <strong>to</strong>lerance<br />

– Tera<strong>to</strong>geneous action<br />

69. Secondary malignance caused by leukopoiesis inhibi<strong>to</strong>rs is<br />

– Direct <strong>to</strong>xic effect<br />

– Manifestation of idiosyncrasy<br />

– Allergic reaction<br />

– Cancerogeneous action<br />

– Tera<strong>to</strong>geneous action<br />

70. Neuro<strong>to</strong>xicity of strep<strong>to</strong>mycin is<br />

– Direct <strong>to</strong>xic action<br />

– Manifestation of idiosyncrasy<br />

– Allergic reaction<br />

– Cancerogeneous action<br />

– Tera<strong>to</strong>geneous action<br />

71. “Tetracycline teeth” in baby caused by tetracycline which his mother used in the<br />

period of pregnance are the manifestation of<br />

– Direct <strong>to</strong>xic action<br />

– Idiosyncrasy<br />

– Allergic reaction<br />

– Cancerogeneous action<br />

– Tera<strong>to</strong>geneous action<br />

72. Hemolysis of red blood cells caused by quinine in patients with deficit of<br />

glucose-6- phosphate dehydrogenase is<br />

– Direct <strong>to</strong>xic action<br />

– Idiosyncrasy<br />

– Allergic reaction<br />

– Cancerogeneous action<br />

– Tera<strong>to</strong>geneous action<br />

73. Loss of pain sensation in the site of administration of lidocaine is<br />

– Local action<br />

15


– Resorbtive action<br />

– Reflexive action<br />

– Selective action<br />

– Irreversible action<br />

74. Anti-arrhythmic action of lidocaine after its aborbtion in<strong>to</strong> the blood is<br />

– Local action<br />

– Resorbtive action<br />

– Reflexive action<br />

– Selective action<br />

– Irreversible action<br />

75. Anti-cancer drugs disturb reduplication of DNA, so they have<br />

– Genom-tropic mechanism of action<br />

– Membrane- tropic mechanism of action<br />

– Enzyme- tropic mechanism of action<br />

– Recep<strong>to</strong>r mechanism of action<br />

– None of listed<br />

76. Procaine disturbs sodium ions transport through membrane, so it has<br />

– Genom-tropic mechanism of action<br />

– Membrane- tropic mechanism of action<br />

– Enzyme- tropic mechanism of action<br />

– Recep<strong>to</strong>r mechanism of action<br />

– None of listed<br />

77. Neostigmine blocks acetylcholine esterase, so it has<br />

– Genom-tropic mechanism of action<br />

– Membrane- tropic mechanism of action<br />

– Enzyme- tropic mechanism of action<br />

– Recep<strong>to</strong>r mechanism of action<br />

– None of listed<br />

78. Atropine blocks M-cholinorecep<strong>to</strong>rs, so it has<br />

– Genom-tropic mechanism of action<br />

– Membrane- tropic mechanism of action<br />

– Enzyme- tropic mechanism of action<br />

– Recep<strong>to</strong>r mechanism of action<br />

– None of listed<br />

79. Cardiac glycosides act on myocardium, improve blood circulation in the kidney<br />

and increase diuresis. It is<br />

– Direct action on kidney<br />

– Indirect action on kidney<br />

– Local action in kidney<br />

– Reflexive action on kidney<br />

– Irreversible action<br />

80. Cardiac glycosides act on myocardium and increase its contractions and <strong>to</strong>ne. It<br />

is<br />

– Direct action<br />

– Indirect action<br />

16


– Local action<br />

– Reflexive action<br />

– Irreversible action<br />

81. Validolum irritates nerve endings in mucous membrane of oral cavity, initiates<br />

reflexes and delays coronary spasm. It is<br />

– Direct action<br />

– Indirect action<br />

– Local action<br />

– Reflexive action<br />

– Irreversible action<br />

82. Anti-cancer antibiotic adriamycin disturbs reduplication of DNA and causes cell<br />

death. It is<br />

– Irreversible action<br />

– Reversible action<br />

– Local action<br />

– Reflexive action<br />

– Adverse action<br />

83. Half-life of the drug is<br />

– Duration of drug’s action<br />

– The time during which concentration of the drug is decreased in 2 times<br />

– The time during which concentration of the drug is decreased in 4 times<br />

– The time during which the drug is completely eliminated<br />

– The time during which the drug is completely excreted<br />

84. Quantitative characteristics of drug’s pharmacokinetics are all except<br />

– Half-life<br />

– Clearance<br />

– Volume of distribution<br />

– Bioavailability<br />

– Tolerance<br />

85. All concerning biotrans<strong>for</strong>mation of drugs is true except<br />

– Stage I reactions are non-synthetic<br />

– Stage II reactions are synthetic<br />

– Microsomal drug oxidation/reduction system is the P-450 system<br />

– Cy<strong>to</strong>chrome P-450 is inducible<br />

– The P-450 system is not responsible <strong>for</strong> the metabolism of many drugs<br />

86. Inducers of microsomal oxidation are drugs which<br />

– Increase the activity of cy<strong>to</strong>chrome P-450<br />

– Decrease the activity of cy<strong>to</strong>chrome P-450<br />

– Increase the activity of glucuronide conjugation<br />

– Inhibit all liver enzymes<br />

– Induce all liver enzymes<br />

87. Inhibi<strong>to</strong>rs of microsomal oxidation are drugs which<br />

– Increase the activity of cy<strong>to</strong>chrome P-450<br />

– Decrease the activity of cy<strong>to</strong>chrome P-450<br />

– Increase the activity of glucuronide conjugation<br />

17


– Inhibit all liver enzymes<br />

– Induce all liver enzymes<br />

88. Phenobarbital is the inducer of microsomal oxidation, that’s why it changes<br />

biotrans<strong>for</strong>mation of another drugs<br />

– Co-administered drugs are biotrans<strong>for</strong>med more rapidly<br />

– Co-administered drugs are biotrans<strong>for</strong>med more slowly<br />

– Co-administered drugs are accumulated in the body<br />

– Co-administered drugs are excreted more rapidly<br />

– Co-administered drugs are not biotrans<strong>for</strong>med<br />

89. Metronidazole is the inhibi<strong>to</strong>r of microsomal oxidation, that’s why it changes<br />

biotrans<strong>for</strong>mation of another drugs<br />

– Co-administered drugs are biotrans<strong>for</strong>med more rapidly<br />

– Co-administered drugs are biotrans<strong>for</strong>med more slowly<br />

– Co-administered drugs are accumulated in the body<br />

– Co-administered drugs are excreted more rapidly<br />

– Co-administered drugs are not biotrans<strong>for</strong>med<br />

90. Dose of drug <strong>for</strong> child should be<br />

– More than adult dose<br />

– Similar <strong>to</strong> adult dose<br />

– Less than adult dose<br />

– Minimal therapeutic dose<br />

– Threshold dose<br />

91. Dose of drug <strong>for</strong> elderly patients should be<br />

– More than adult dose<br />

– Similar <strong>to</strong> adult dose<br />

– Less than adult dose<br />

– Minimal therapeutic dose<br />

– Threshold dose<br />

92. After stage I of biotras<strong>for</strong>mation<br />

– All metabolites are active<br />

– All metabolites are inactive<br />

– Metabolites are active and inactive<br />

– Metabolites are not <strong>for</strong>med<br />

– None of above listed<br />

93. After stage II of biotras<strong>for</strong>mation<br />

– All metabolites are active<br />

– All metabolites are inactive<br />

– Metabolites are active and inactive<br />

– Metabolites are not <strong>for</strong>med<br />

– None of above listed<br />

94. If the drug is unbound in plasma, it<br />

– Is active and has rapid onset of action<br />

– Is inactive<br />

– Has slow onset of action<br />

– Does not enter tissues<br />

18


– Is not metabolized in the liver<br />

95. Cholinomimetics may cause all the following side-effects except<br />

– Bradycardia<br />

– Bronchospasm<br />

– Hypersalivation<br />

– Constipation and urinary retention<br />

– Sweating<br />

96. Ephedrine exerts all effects except<br />

– Releases s<strong>to</strong>red noradrenaline from nerve terminals<br />

– Produces bronchodilatation<br />

– Stimulates CNS<br />

– Rises sys<strong>to</strong>lic blood pressure<br />

– Produces atrio-ventricular block<br />

97. Propranolol (Anaprilinum) is effective in the treatment of hypertension due <strong>to</strong><br />

– Blockage of β2 –adrenocep<strong>to</strong>rs and increase in peripheral vascular <strong>to</strong>ne<br />

– Blockage of β1 –adrenocp<strong>to</strong>rs and decrease of cardiac output<br />

– Inhibition of norepinephrine release from presynaptic membrane<br />

– Myotropic action<br />

– Action on CNS<br />

98. Anticholinesterases are used <strong>for</strong> treatment of all diseases except<br />

– Atropine (belladonna) poisoning<br />

– Pos<strong>to</strong>perative paralytic ileus (a<strong>to</strong>nia of intestines)<br />

– Overdose of depolarizing myorelaxants<br />

– Myasthenia gravis<br />

– Glaucoma<br />

99. Dobutamine is selective β-adrenomimetic <strong>for</strong> treatment of<br />

– Acute heart failure<br />

– Bronchial asthma<br />

– Tachycardia<br />

– Hypertension<br />

– Angina pec<strong>to</strong>ris<br />

100. Side-effects of sympatholytics are all except<br />

– Hypotension<br />

– Dry mouth<br />

– Bradycadria<br />

– Gastritis<br />

– Disturbances of sleeping<br />

101. The following in<strong>for</strong>mation concerning anticholinesterases is correct except<br />

– They are used <strong>for</strong> treatment of paralysis<br />

– Galanthamine penetrates through blood-brain barrier<br />

– Phosphacolum is longer acting than neostigmine (Proserinum)<br />

– Reactiva<strong>to</strong>rs of cholinesterase are used in treatment of belladonna poisoning<br />

– Reactiva<strong>to</strong>rs of cholinesterase are effective in the poisoning with organophosphates<br />

102. Atropine causes<br />

19


– Spasm of accomodation<br />

– Cycloplegia<br />

– Miosis<br />

– Decrease in intraocular pressure<br />

– Any ocular effects<br />

103. Atropine exerts<br />

– Spasm of smooth muscles<br />

– Bradycardia<br />

– Decrease in gastric secretion<br />

– Increase in salivation<br />

– Increase in sweat secretion<br />

104. Atropine is M-cholinoblocker which causes<br />

– Spasm of bronchi<br />

– Dilation of bronchi<br />

– Hypersecretion of bronchial glands<br />

– Increase in motility of the gut<br />

– Increase in <strong>to</strong>ne of urinary bladder<br />

105. Atropine blocks<br />

– M-cholinorecep<strong>to</strong>rs of all subtypes<br />

– M1-cholinorecep<strong>to</strong>rs<br />

– N-cholinorecep<strong>to</strong>rs of all subtypes<br />

– N-cholinorecep<strong>to</strong>rs of ganglionic subtype<br />

– N-cholinorecep<strong>to</strong>rs of muscular subtype<br />

106. Atropine is<br />

– Non-celective cholinoblocker<br />

– Selective cholinoblocker<br />

– Non-selective adrenergic agonist<br />

– Selective adrenergic agonist<br />

– Non-selective adrenergic antagonist<br />

107. Ipratropium bromide is used <strong>to</strong> treat<br />

– Bronchial asthma<br />

– Peptic ulcer of s<strong>to</strong>mach<br />

– Colics<br />

– Bradicardia<br />

– Kine<strong>to</strong>sis<br />

108. Indications <strong>to</strong> use of atropine are all except<br />

– Gastric ulcer<br />

– Colic<br />

– A<strong>to</strong>nia of the gut after the surgery<br />

– Bradycardia<br />

– Preanesthetic medication<br />

109. Indications <strong>to</strong> use of atropine are all except<br />

– Poisoning with morphine<br />

– Poisoning with antichlolinesterases<br />

– Poisoning with <strong>to</strong>xic mushrooms containing muscarine<br />

20


– Prevention of vagal action of general anesthetics<br />

– Belladonna poisoning<br />

110. Side-effects of atropine are all except<br />

– Glaucoma<br />

– Urinary retention<br />

– Dry mouth<br />

– Tachycardia<br />

– Frequent urination<br />

111. Isoprenaline (Isadrinum) is<br />

– Indicated in tachyarrhythmia<br />

– Natural catecholamine<br />

– Bronchodila<strong>to</strong>r<br />

– Depressant of heart function<br />

– Cardioselective adrenomimetic<br />

112. The most long lasting cycloplegia is caused by<br />

– Adrenaline<br />

– Atropine<br />

– Scopolamine<br />

– Platyphylline<br />

– Methacinum<br />

113. Adrenaline is used <strong>to</strong> treat all diseases except<br />

– Acute bronchial asthma<br />

– Hypoglycemic coma<br />

– Anaphylactic shock<br />

– Angina pec<strong>to</strong>ris<br />

– Heart arrest<br />

114. Neostigmine is characterized by<br />

– High ability <strong>to</strong> penetrate CNS<br />

– Effectiveness in treatment of paralysis<br />

– Irreversible inhibition of acetylcholinesterase<br />

– Effectiveness in treating of gastric ulcer<br />

– Its ability <strong>to</strong> cause block of ganglia<br />

115. Pirenzepine is beneficial in the treatment of<br />

– Colics<br />

– Bronchospasm<br />

– Atrio-ventricular block<br />

– Gastric peptic ulcer<br />

– Prevention of vagal reactions during general anesthesia<br />

116. The drug used <strong>to</strong> prevent premature labor is<br />

– Dobutamine<br />

– Me<strong>to</strong>prolol<br />

– Isadrinum<br />

– Adrenaline<br />

– Partusisten (Fenoterol)<br />

21


117. Cholinoblockers which may cause dry mouth as side-effect are all except<br />

– Hyoscine<br />

– Atropine<br />

– Methacinum<br />

– Pilocarpine<br />

– Platyphylline<br />

118. α-adrenoblockers are used <strong>for</strong> all the following except<br />

– Diagnostics of pheochromocy<strong>to</strong>ma<br />

– Treatment of pheochromocy<strong>to</strong>ma<br />

– Treatment of Raynaud's disease (spasms of blood vessels)<br />

– Treatment of hypertension<br />

– Treatment of angina pec<strong>to</strong>ris<br />

119. M-cholinoblocker used in motion sickness is<br />

– Scopolamine<br />

– Atropine<br />

– Plathyphylline<br />

– Pirenzepine<br />

– Ipratropium bromide<br />

120. Decrease in vascular <strong>to</strong>ne following reserpine administration is due <strong>to</strong><br />

– Antagonism of noradrenaline action<br />

– Depletion of noradrenaline s<strong>to</strong>re<br />

– Inhibition of MAO<br />

– Inhibition of noradrenaline synthesis<br />

– Direct relaxation of smooth muscle of blood vessels<br />

121. Dimedrolum is applied in a clinic <strong>for</strong> all except<br />

– Treatment of gastric ulcer<br />

– Allergic dermatitis<br />

– Allergic complications of pharmacological therapy<br />

– Hemorrhagical diathesis<br />

– Treatment of insomnia<br />

122. Pain in skeletal muscles may complicate the use of<br />

– Lobeline<br />

– Mellictinum<br />

– D-tubocurarine<br />

– Succinylcholine (Dithylinum)<br />

– Neostigmine<br />

123. The following statement concerning prazosin is not correct<br />

– It blocks α1-adrenocep<strong>to</strong>rs<br />

– It causes vasodilatation<br />

– It blocks α2-adrenorecep<strong>to</strong>rs<br />

– It does not cause tachycardia<br />

– It is used <strong>to</strong> treat hypertension<br />

124. Adrenаline is used <strong>for</strong> prolongation of local anesthesia due <strong>to</strong><br />

– Dilation of bronchi<br />

– Inhibition of gut motility<br />

22


– Hyperglycemia<br />

– Inhibiting of absorbtion of local anesthetic due <strong>to</strong> vasoconstriction<br />

– Stimulation of heart work<br />

125. Hyoscine (scopolamine) differs from atropine in all except<br />

– It has central nervous system depressant action<br />

– Mydriasis is longer than that of atropine<br />

– Mydriasis is briefer than that of atropine<br />

– It is effective in prevention of kine<strong>to</strong>sis (motion sickness)<br />

– It causes amnesia<br />

126. All the following are the indications <strong>for</strong> clinical use of propranolol (Anaprilinum),<br />

except<br />

– Hypertension<br />

– Tachyarrhythmia<br />

– Raynaud's disease (spasms of blood vessels)<br />

– Angina pec<strong>to</strong>ris<br />

– Myocardial infarction<br />

127. α-adrenomimetics cause<br />

– Increase in blood pressure<br />

– Cycloplegia<br />

– Miosis<br />

– Bronchodilation<br />

– Hyperglycemia<br />

128. α-adrenomimetics applied <strong>to</strong>pically on mucous membrane of the nose cause<br />

– Increase in blood pressure<br />

– Spasm of accomodation and miosis<br />

– Vasoconctriction and decrease in exudation<br />

– Bronchodilation<br />

– Hyperglycemia<br />

129. Pilocarpine is<br />

– M-cholinoblocker<br />

– Used <strong>for</strong> investigation of eye bot<strong>to</strong>m<br />

– Used <strong>for</strong> selection of glasses<br />

– Used <strong>for</strong> treatment of glaucoma<br />

– Used in patients with bronchial asthma<br />

130. In the case of Belladonna poisoning neostigmine will antagonize the following<br />

symp<strong>to</strong>ms except<br />

– Palpitation<br />

– Dryness of mouth<br />

– Hallucination<br />

– Blurring of vision<br />

– Urinary retention<br />

131. α-adrenocep<strong>to</strong>r blockers may cause the following side-effect<br />

– Postural hypotension<br />

– Reflex bradycardia<br />

– Decrease in intestinal motility<br />

23


– Hypersalivation<br />

– Disturbances in taste sensation<br />

132. α-adrenoblockers may cause the following side-effects except<br />

– Postural hypotension<br />

– Reflex tachycardia<br />

– Increase in intestinal motility<br />

– Inhibition of ejaculation<br />

– Constipation<br />

133. The patient is suffering from myastenia gravis. The drug <strong>for</strong> his treatment is<br />

– Neostigmine<br />

– Lobeline<br />

– Atropine<br />

– Plathyphylline<br />

– Pilocarpine<br />

134. The patient is suffering from paralysis after insult. The drug <strong>for</strong> its treatment is<br />

– Galanthamine<br />

– Lobeline<br />

– Atropine<br />

– Plathyphylline<br />

– Pilocarpine<br />

135. Belladonna poisoning is diagnosed in a patient. The antidote in this poisoning<br />

is<br />

– Neostigmine<br />

– Lobeline<br />

– Aceclidinum<br />

– Plathyphylline<br />

– Pilocarpine<br />

136. A patient with glaucoma is prescribed with M-cholinomimetic. This drug is<br />

– Neostigmine<br />

– Lobeline<br />

– Cyti<strong>to</strong>num<br />

– Plathyphylline<br />

– Pilocarpine<br />

137. Pirenzepine was prescribed <strong>to</strong> treat gastric ulcer. It is from the group of<br />

– M-cholinergic agonists<br />

– M,N-cholinergic agonists<br />

– N-cholinergic agonists<br />

– Non-selective M-cholinoblockers<br />

– Selective M-cholinoblockers<br />

138. Lobeline was given IV in respira<strong>to</strong>ry arrest. It is from the group of<br />

– M-cholinergic agonists<br />

– M-, N-cholinergic agonists<br />

– N- cholinergic agonists<br />

– Anticholinesterases<br />

– M-cholinoblockers<br />

24


139. Lobeline<br />

– Stimulates M-cholinergic recep<strong>to</strong>rs<br />

– Stimulates M- and N-cholinergic recep<strong>to</strong>rs<br />

– Stimulates N-cholinergic recep<strong>to</strong>rs<br />

– Is myorelaxant<br />

– Is ganglionic blocker<br />

140. Stimulation of respiration by Cyti<strong>to</strong>num is due <strong>to</strong><br />

– Stimulation of N-cholinergic recep<strong>to</strong>rs in CNS<br />

– Stimulation of N-cholinergic recep<strong>to</strong>rs in adrenal medula<br />

– Stimulation of N-cholinergic recep<strong>to</strong>rs in zona carotis<br />

– Stimulation of N-cholinergic recep<strong>to</strong>rs in skeletal muscles<br />

– Stimulation of N-cholinergic recep<strong>to</strong>rs in ganglia<br />

141. Myorelaxation caused by tubocurarine is due <strong>to</strong><br />

– Blockage of N-cholinergic recep<strong>to</strong>rs in CNS<br />

– Blockage of N-cholinergic recep<strong>to</strong>rs in adrenal medula<br />

– Blockage of N-cholinergic recep<strong>to</strong>rs in zona carotis<br />

– Blockage of N-cholinergic recep<strong>to</strong>rs in skeletal muscles<br />

– Blockage of N-cholinergic recep<strong>to</strong>rs in ganglia<br />

142. Tubocurarine is<br />

– Antidepolarizing myorelaxant<br />

– Depolarizing myorelaxant<br />

– Local anesthetic<br />

– General anesthetic<br />

– Anticholinesterase<br />

143. Overdose of tubocurarine should be treated with<br />

– Neostigmine<br />

– Reactiva<strong>to</strong>rs of cholinesterase<br />

– Lobeline<br />

– Atropine<br />

– Apomorphine<br />

144. Myorelaxation by tubocurarine is used<br />

– In surgeries under general anesthesia<br />

– In diagnostic investigations<br />

– In shock<br />

– In local anesthesia<br />

– In all listed cases<br />

145. All concerning pharmacokinetics of adrenaline is true except<br />

– It is administered SC<br />

– It is used <strong>to</strong>pically<br />

– It is well absorbed in the gut<br />

– It is destroyed in the blood<br />

– Its duration of action is 15-30 min<br />

146. Adrenaline (<strong>to</strong>pically) s<strong>to</strong>ps capillary bleeding due <strong>to</strong><br />

– Dilation of bronchi<br />

25


– Stimulation of heart contractions<br />

– Increase in glucose level in blood<br />

– Increase in BP<br />

– Constriction of blood vessels<br />

147. Noradrenaline is administered in<br />

– Spasm of bronchi<br />

– Bleeding<br />

– Heart arrest<br />

– Arrhythmia<br />

– Collapse<br />

148. Adremomimetic <strong>for</strong> intracardial administration in heart arrest is<br />

– Adrenaline<br />

– Noradrenaline<br />

– Ephedrine<br />

– Isoprenaline (Isadrinum)<br />

– Salbutamol<br />

149. Indirect acting adrenomimetic with psychostimulant action is<br />

– Adrenaline<br />

– Noradrenaline<br />

– Ephedrine<br />

– Isoprenaline (Isadrinum)<br />

– Salbutamol<br />

150. Adrenomimetic which may cause <strong>to</strong>lerance and drug dependence is<br />

– Adrenaline<br />

– Phenylephrin (Meza<strong>to</strong>num)<br />

– Ephedrine<br />

– Isoprenaline (Isadrinum)<br />

– Salbutamol<br />

151. A patient has bronchial asthma co-existing with tachycardia. In this case the<br />

best preparation is<br />

– Adrenaline<br />

– Noradrenaline<br />

– Ephedrine<br />

– Isoprenaline (Isadrinum)<br />

– Salbutamol<br />

152. Adrenergic agonist in the <strong>for</strong>m of nasal drops is<br />

– Phenylephrin (Meza<strong>to</strong>num)<br />

– Noradrenaline<br />

– Naphazoline (Naphthizinum)<br />

– Isoprenaline (Isadrinum)<br />

– Salbutamol<br />

153. True in<strong>for</strong>mation concerning the location of cholinergic recep<strong>to</strong>rs is<br />

– M- cholinergic recep<strong>to</strong>rs are situated in CNS<br />

– M- cholinergic recep<strong>to</strong>rs are situated in exocrinal glands<br />

– M- cholinergic recep<strong>to</strong>rs are situated in smooth muscles<br />

26


– M- cholinergic recep<strong>to</strong>rs are situated in myocardium<br />

– All listed<br />

154. True in<strong>for</strong>mation concerning the location of cholinergic recep<strong>to</strong>rs is<br />

– N- cholinergic recep<strong>to</strong>rs are situated in CNS<br />

– N- cholinergic recep<strong>to</strong>rs are situated in ganglia<br />

– N- cholinergic recep<strong>to</strong>rs are situated in skeletal muscles<br />

– N- cholinergic recep<strong>to</strong>rs are situated in zona carotis<br />

– All listed<br />

155. True in<strong>for</strong>mation concerning cholinergic recep<strong>to</strong>rs is<br />

– M-cholinergic recep<strong>to</strong>rs are stimulated by muscarine and inhibited by atropine<br />

– N-cholinergic recep<strong>to</strong>rs are stimulated and inhibited by tubocurarine<br />

– N- cholinergic recep<strong>to</strong>rs are stimulated by ganglionic blockers<br />

– M- and N-cholinergic recep<strong>to</strong>rs are not located in CNS<br />

– N-cholinergic recep<strong>to</strong>rs are not stimulated and inhibited by nicotine<br />

156. True in<strong>for</strong>mation concerning the location of adrenocep<strong>to</strong>rs is<br />

– α1-adrenocep<strong>to</strong>rs are located in blood vessels<br />

– α2-adrenocep<strong>to</strong>rs are located on presynaptic membrane of all sympathetic synapses<br />

– β1 - adrenocep<strong>to</strong>rs are located in the heart<br />

– β2 -adrenocep<strong>to</strong>rs are located in bronchi<br />

– All mentioned<br />

157. True in<strong>for</strong>mation concerning adrenocep<strong>to</strong>rs is<br />

– α1-adrenocep<strong>to</strong>rs are located in blood vessels and constrict them<br />

– β2 -adrenocep<strong>to</strong>rs are located in blood vessels and dilate them<br />

– β1 - adrenocep<strong>to</strong>rs are located in the heart and stimulate heart work<br />

– β2 -adrenocep<strong>to</strong>rs are located in bronchi and dilate them<br />

– All mentioned<br />

158. Succinylcholine (Dithylinum) is<br />

– Depolarizing myorelaxant<br />

– Anti- depolarizing myorelaxant<br />

– Anticholinesterase<br />

– Adrenergic agent<br />

– Anesthetic<br />

159. Succinylcholine (Dithylinum)<br />

– Is depolarizing myorelaxant<br />

– Has short duration of action<br />

– May cause long-lasting apnea in some patients<br />

– Anesthetic <strong>for</strong> short surgeries<br />

– All listed<br />

160. If succinylcholine has caused apnea, emergence help is<br />

– Neostigmine<br />

– Reactiva<strong>to</strong>rs of cholinesterase<br />

– Blood transfusion and appara<strong>to</strong>us lungs ventilation<br />

– Forced diuresis<br />

– Adrenaline (intracardialy)<br />

27


161. Succinylcholine causes long-lasting apnea in patients with<br />

– Deficit of pseudo cholinesterase<br />

– Deficit of MAO<br />

– Deficit of COMT<br />

– Deficit of G-6-PDG<br />

– None of listed<br />

162. Ganglionic blockers<br />

– Block N-cholinorecep<strong>to</strong>rs in parasympathetic ganglia<br />

– Block N-cholinorecep<strong>to</strong>rs in sympathetic ganglia<br />

– Block N-cholinorecep<strong>to</strong>rs in skeletal muscles<br />

– Block N-cholinorecep<strong>to</strong>rs in CNS<br />

– Block N-cholinorecep<strong>to</strong>rs both in parasympathetic and sympathetic ganglia<br />

163. Ganglionic blockers are used in all cases except<br />

– Collapse<br />

– Colic<br />

– Acute hypertension<br />

– Controlled hypotension in surgeries<br />

– Bronchial asthma attack<br />

164. Only one preparation belongs <strong>to</strong> ganglionic blockers<br />

– Hexamethonium (Benzohexonium)<br />

– Succinylcloline<br />

– Tubocurarine<br />

– Atropine<br />

– Hyoscine (Scopolamine)<br />

165. Hygronium is used in<br />

– Collapse<br />

– Bleeding from bigger blood vessels<br />

– Controlled hypotension<br />

– Neuroleptanalgesia<br />

– Thrombosis<br />

166, To treat allergic complications of drugs therapy they use<br />

– Blockers of H1-histamine recep<strong>to</strong>rs<br />

– Blockers of H2-histamine recep<strong>to</strong>rs<br />

– Blockers of adrenergic recep<strong>to</strong>rs<br />

– Blockers cholinergic recep<strong>to</strong>rs<br />

– Cholinergic agonists<br />

167. A patient with allergic dermatitis was prescribed with antihistamine drug. This<br />

preparation is<br />

– Diphenhydramine (Dimedrolum)<br />

– Ranitidine<br />

– Prednisolone<br />

– Methyluracilum<br />

– Adrenaline<br />

168. H1-histaminoblocker without sedative effect was prescribed <strong>to</strong> treat allergic<br />

complication of pharmacotherapy. It is<br />

28


– Diphenhydramine (Dimedrolum)<br />

– Suprastinum<br />

– Diazolinum<br />

– Ranitidine<br />

– Cromolyn sodium<br />

169. Antihistaminic drug which my be used <strong>to</strong> treat insomnia is<br />

– Diphenhydramine (Dimedrolum)<br />

– Ephedrine<br />

– Diazolinum<br />

– Ranitidine<br />

– Cromolyn sodium<br />

170. Mast cell stabilizer <strong>to</strong> treat bronchial asthma is<br />

– Diphenhydramine (Dimedrolum)<br />

– Suprastinum<br />

– Diazolinum<br />

– Ranitidine<br />

– Cromolyn sodium<br />

171. H1-histaminoblocker with sedative effect was prescribed <strong>to</strong> treat urticaria. It is<br />

– Diphenhydramine (Dimedrolum)<br />

– Prednisolone<br />

– Diazolinum<br />

– Ranitidine<br />

– Cromolyn sodium<br />

172. Diphenhydramine exerts all effects except<br />

– Anti-allergic<br />

– Anti-inflamma<strong>to</strong>ry<br />

– Anti-muscarinic<br />

– Sedative<br />

– Antianginal<br />

173. Side-effects of diphenhydramine (Dimedrolum) are all except<br />

– Somnolence<br />

– Dry mouth<br />

– Hypotension<br />

– Tolerance<br />

– Vomiting<br />

174. Histamine exerts the following effects except<br />

– Vasodilation<br />

– Tachycardia<br />

– Decrease in BP<br />

– Increase in gastric secretion<br />

– Bronchodilation<br />

175. Allergic disease in which H1-histaminoblockers are poorly effective is<br />

– Urticaria<br />

– Hey fever<br />

– Bronchial asthma<br />

29


– Serum sickness<br />

– None of listed<br />

176. Drug which must be urgently administered in anaphylactic shock is<br />

– Diphenhydramine<br />

– Cromolyn sodium<br />

– Noradrenaline<br />

– Adrenaline<br />

– Phenylephrine<br />

177. A patient has ulcer of s<strong>to</strong>mach. Antihistaminic agent <strong>for</strong> his treatment is<br />

– Ranitidine<br />

– Dimedrolum<br />

– Diazolinum<br />

– Suprastinum<br />

– Cromolyn sodium<br />

178. There are two groups of local anesthetics<br />

– Typical and atypical<br />

– Narcotic and non-narcotic<br />

– Liquid and non-liquid<br />

– Esters of PABA and amides<br />

– Inhalation and IV<br />

179. Local anesthetics from esters group are all except<br />

– Procaine (Novocainum)<br />

– Tetracaine (Dicainum)<br />

– Benzocaine (Anaesthesinum)<br />

– Cocaine<br />

– Lidocaine (Xycainum)<br />

180. Local anesthetic from amides group is only<br />

– Procaine (Novocainum)<br />

– Tetracaine (Dicainum)<br />

– Benzocaine (Anaesthesinum)<br />

– Cocaine<br />

– Lidocaine (Xycainum)<br />

181. Anesthetic <strong>for</strong> all kinds of local anesthesia is<br />

– Procaine (Novocainum)<br />

– Tetracaine (Dicainum)<br />

– Benzocaine (Anaesthesinum)<br />

– Cocaine<br />

– Lidocaine (Xycainum)<br />

182. Anesthetic only <strong>for</strong> surface local anesthesia is<br />

– Procaine (Novocainum)<br />

– Tetracaine (Dicainum)<br />

– Trimecaine<br />

– Sovcaine<br />

– Lidocaine (Xycainum)<br />

30


183. Local anesthetic used only <strong>for</strong> surface anesthesia in burns, wounds, diseases<br />

of skin and mucous membanes is<br />

– Procaine (Novocainum)<br />

– Tetracaine (Dicainum)<br />

– Trimecaine<br />

– Benzocaine (Anaesthesinum)<br />

– Lidocaine (Xycainum)<br />

184. Benzocaine (Anaesthesinum) is used <strong>for</strong> surface anesthesia only because of<br />

its<br />

– High <strong>to</strong>xicity<br />

– Poor water solubility<br />

– High potency<br />

– Anti-arrhythmic action<br />

– Vasodilation<br />

185. Local anesthetics realize their action by<br />

– Binding <strong>to</strong> recep<strong>to</strong>rs<br />

– Specifically plugging sodium channels<br />

– Coupling with G-protein<br />

– Action on enzymes<br />

– Action on carrier molecule<br />

186. Procaine is<br />

– Local anesthetic from amides group<br />

– The most potent local anesthetic<br />

– Used only <strong>for</strong> surface anesthesia<br />

– Used <strong>for</strong> infiltration, conductive, and spinal anesthesia<br />

– The most <strong>to</strong>xic local anesthetic<br />

187. Lidocaine has the following advantages over procaine except<br />

– Longer duration of action<br />

– Suitable <strong>for</strong> all types of anesthesia<br />

– No interaction with sulphonamides<br />

– Less allergic properties<br />

– Minimal effect on the heart<br />

188. Local anesthetics have the following common properties except<br />

– They are bases<br />

– The anesthetic activity rises at alkaline pH<br />

– Ester local anesthetics are metabolized by esterases in blood<br />

– Amide local anesthetics are metabolized by hepa<strong>to</strong>cytes<br />

– Duration of action of esters is longer than that of amides<br />

189. Lidocaine is used in<br />

– Infiltration anesthesia only<br />

– All kinds of anesthesia<br />

– Surface anesthesia only<br />

– Spinal anesthesia only<br />

– None of above listed<br />

190. Local anesthetic with significant anti-arrhythmic properties is only<br />

31


– Procaine (Novocainum)<br />

– Tetracaine (Dicainum)<br />

– Benzocaine (Anaesthesinum)<br />

– Cocaine<br />

– Lidocaine (Xycainum)<br />

191. Non-organic astringent is<br />

– Tannin<br />

– Bark of oak<br />

– Activated charcoal<br />

– Mustard seeds<br />

– Bismuth subnitrate<br />

192 Tannin has the following properties except<br />

– It <strong>for</strong>ms albuminate<br />

– It protects nerve endings in mucous membrane<br />

– It precipitate alkaloids in the gut<br />

– It neutralizes gastric juice<br />

– It is used <strong>for</strong> gargling in s<strong>to</strong>matitis and paradontitis<br />

193. Tannin realizes its anti-inflammation action due <strong>to</strong><br />

– Formation of albuminates on the surface of mucous membrane<br />

– Adsorbtion of <strong>to</strong>xic substances<br />

– Formation of colloidal covering on the mucous membrane<br />

– Local anesthesia<br />

– Irritation of sensitive nerve endings<br />

194. Activated charcoal realizes its action due <strong>to</strong><br />

– Formation of albuminates on the surface of mucous membrane<br />

– Adsorbtion of <strong>to</strong>xic substances<br />

– Formation of colloidal covering on the mucous membrane<br />

– Local anesthesia<br />

– Irritation of sensitive nerve endings<br />

195. Mucus of starch realizes its action due <strong>to</strong><br />

– Formation of albuminates on the surface of mucous membrane<br />

– Adsorbtion of <strong>to</strong>xic substances<br />

– Formation of colloidal covering on the mucous membrane<br />

– Local anesthesia<br />

– Irritation of sensitive nerve endings<br />

196. Mustard seeds realize their action by<br />

– Formation of albuminates on the surface of mucous membrane<br />

– Adsorbtion of <strong>to</strong>xic substances<br />

– Formation of colloidal covering on the mucous membrane<br />

– Local anesthesia<br />

– Irritation of sensitive nerve endings<br />

197. Menthol is characterized by all except<br />

– Irritation of sensitive nerve endings<br />

– Reflexive action on coronary blood vessels<br />

– Constriction of blood vessels in the site of application<br />

32


– Vasodilation in the site of application<br />

– Inhibition of edema and exudation of the upper airways (by inhalation)<br />

198. Reflexly acting expec<strong>to</strong>rant is<br />

– Sodium hydrocarbonate<br />

– Trypsin<br />

– Mucaltinum<br />

– Infusion from the grass of Thermopsis<br />

– Both Mucaltinum and infusion from the grass of Thermopsis<br />

199. All drugs irritates sensitive nerve endings except<br />

– Expec<strong>to</strong>rants<br />

– Irritants<br />

– Laxatives<br />

– Emetics<br />

– Protectives<br />

200. Laxative used in acute poisonings is<br />

– Cas<strong>to</strong>r oil<br />

– Phenolphtalein<br />

– Magnesium sulphate<br />

– Root of Rheum<br />

– None of listed<br />

201. Bitters are<br />

– Stimula<strong>to</strong>rs of appetite<br />

– Suppressors of appetite<br />

– Drugs <strong>for</strong> replacement therapy<br />

– Antimicrobial drugs <strong>for</strong> treatment of peptic ulcer<br />

– Suppressors of gastric secretion<br />

202. Laxatives used in chronic constipation are all except<br />

– Cas<strong>to</strong>r oil<br />

– Bisacodyl<br />

– Magnesium sulphate<br />

– Root of Rheum<br />

– Leaves of Senna<br />

203. Activated charcoal (Carbo activatus) is used <strong>to</strong> treat all diseases except<br />

– Acute poisoning<br />

– Dyspepsia<br />

– Meteorism<br />

– Peptic ulcer<br />

– Chronic in<strong>to</strong>xication<br />

204. Irritant <strong>for</strong> emergence help in syncope is<br />

– Menthol<br />

– Mustard plaster<br />

– Solution of ammonia<br />

– Lobeline<br />

– Atropine<br />

33


205. Ambroxol is<br />

– Expec<strong>to</strong>rant stimulating surfactant synthesis<br />

– Mucolytic<br />

– Non-narcotic antitussive preparation<br />

– Narcotic antitussive preparation<br />

– Emetic with central action<br />

206. Irritant applied in the <strong>for</strong>m of plaster (Charta Sinapis) is<br />

– Mustard<br />

– Menthol<br />

– Solution of ammonia<br />

– Camphor<br />

– Decoction from the seeds of flax (Linum)<br />

207. The antiepileptic drug acting by inhibition of GABA-transaminase is<br />

– Phenobarbital<br />

– Sodium valproate<br />

– Diazepam<br />

– Carbamazepine<br />

– Pheny<strong>to</strong>in<br />

208. Opioid analgesics cause analgesia by action on<br />

– μ-recep<strong>to</strong>rs<br />

– M-cholinorecep<strong>to</strong>rs<br />

– Adrenocep<strong>to</strong>rs<br />

– D2-recep<strong>to</strong>rs<br />

– H1-recep<strong>to</strong>rs<br />

209. The following in<strong>for</strong>mation concerning cheese syndrome is correct except<br />

– It is occurred in patients treated with MAO inhibi<strong>to</strong>rs after use products containing<br />

tyramine<br />

– It is occurred in patients treated with MAO inhibi<strong>to</strong>rs after use of products containing<br />

proteins<br />

– It is manifested by hypertensive crisis and cerebrovascular accidents<br />

– Cheese syndrome has <strong>to</strong> be treated by IV injection of �-adrenoblocker<br />

– Cheese syndrome is due <strong>to</strong> inhibition of MAO in the liver and intestinal wall<br />

210. Piracetam is effective in all cases except<br />

– Disturbance of movement in patients with cerebral stroke<br />

– Retardation of mental development in children<br />

– Disturbances of memory after stroke<br />

– Senile dementia<br />

– Memory impairment in alcoholics<br />

211. Nitrous oxide is characterized by the following properties except<br />

– Good analgesia<br />

– Quick action<br />

– Poor muscle relaxation<br />

– High liver <strong>to</strong>xicity<br />

34


– Usage in obstetrics and dental surgery<br />

212. Levodopa is used <strong>for</strong> replacement therapy of Parkinson's disease instead of<br />

dopamine due <strong>to</strong> its<br />

– High efficacy<br />

– Ability <strong>to</strong> penetrate blood-brain barrier<br />

– Ability <strong>to</strong> trans<strong>for</strong>m in<strong>to</strong> dopamine<br />

– Ability <strong>to</strong> inhibit cholinorecep<strong>to</strong>rs<br />

– Both ability <strong>to</strong> penetrate CNC and trans<strong>for</strong>mation in<strong>to</strong> dopamine<br />

213. Nootropic drugs cause the following effects<br />

– Improvement of acquisition of new knowledge<br />

– Improvement of memory<br />

– Increase in brain stability <strong>to</strong> hypoxia<br />

– Improvement of cerebral circulation<br />

– All listed<br />

214. Stage of anesthesia (analgesia stage) is characterized by the following<br />

– Abolishing of pain<br />

– Excitement<br />

– Loss of conscience<br />

– Relaxation of skeletal muscles<br />

– Suppression of reflex activity<br />

215. Morphine exerts all the following CNS effects except<br />

– Euphoria<br />

– Sedation<br />

– Cough suppression<br />

– Analgesia<br />

– Constipation<br />

216. Benzodiazepines used as anxiolytics may cause following side-effects<br />

– Cognitive impairment<br />

– Somnolence<br />

– Impairment of fine mo<strong>to</strong>r coordination<br />

– Drug dependence<br />

– All listed above<br />

217. The indications <strong>for</strong> clinical use of antidepressants include<br />

– Reactive depression<br />

– Endogenous depression<br />

– Enuresis in children<br />

– Pain syndromes<br />

– All listed<br />

218. Barbiturates may cause all following side-effects except<br />

– After-action<br />

– Tolerance<br />

35


– Suppression of REM sleep<br />

– Drug dependence<br />

– Euphoria<br />

219. As antidote in bromism the following agent is used<br />

– Sodium hydrocarbonate<br />

– Magnesium sulfate<br />

– Sodium chloride<br />

– Magnesium oxide<br />

– Calcium chloride<br />

220. Imipramine exerts the following effects except<br />

– Decrease in depression<br />

– Elevation of mood<br />

– Improvement of communicative behavior<br />

– Improvement of sleep<br />

– Antimuscarinic action<br />

221. The III stage of general anesthesia (stage of surgical anesthesia) is manifested<br />

by<br />

– 4 planes of its development<br />

– Excitement<br />

– Progressive decrease in muscular <strong>to</strong>ne<br />

– Inhibition of reflexes<br />

– All listed except excitement<br />

222. The acute barbiturate poisoning is manifested by all except<br />

– Failing respiration<br />

– Coma<strong>to</strong>se state<br />

– Fall of BP<br />

– Myorelaxation<br />

– Colic<br />

223. The main mechanism of non-opiod analgesics action is<br />

– Inhibition of phosphodiesterase<br />

– Inhibition of cyclooxygenase<br />

– Inhibition of monoamine oxidase<br />

– Increase in noradrenaline release<br />

– Inhibition of dopamine reuptake<br />

224. Caffeine stimulates CNS by<br />

– Increasing in noradrenaline release in CNS<br />

– Stimulating of dopamine recep<strong>to</strong>rs<br />

– Inhibition of cholinorecep<strong>to</strong>rs of CNS<br />

– Inhibition of GABA recep<strong>to</strong>rs<br />

– Blockade of adenosine recep<strong>to</strong>rs<br />

225. Ketamine is<br />

– Long acting general anesthetic<br />

– Increasing cardiac output<br />

– Producing profound analgesia<br />

– Not abolishing reflexes<br />

36


– All listed except long duration of action<br />

226. The clinical uses of barbiturates include<br />

– Depression<br />

– Epilepsy<br />

– Insomnia<br />

– Psychosis<br />

– Both epilepsy and insomnia<br />

227. Non-opioid analgesics exert the following effects except<br />

– Antipyretic<br />

– Immune depressive<br />

– Anti-inflamma<strong>to</strong>ry<br />

– Analgesic<br />

– Anti-platelet<br />

228. Caffeine causes all except<br />

– Increase in mental per<strong>for</strong>mance<br />

– Decrease of fatigue<br />

– Development of drug dependence<br />

– Increase of blood pressure<br />

– Decrease in gastric secretion<br />

229. The endogenous ligands of opoid recep<strong>to</strong>rs are<br />

– Endorphins<br />

– Enkephalins<br />

– Glutaminic acid<br />

– Dynorphins<br />

– Endorphins, enkephalins, and dynorphins<br />

230. Clinical uses of anxiolytics include all the following except<br />

– Anxiety and panic<br />

– Epilepsy<br />

– Complex treatment of withdrawal syndrome in drug dependent patients<br />

– Insomnia<br />

– Acute psychosis<br />

231. The drugs of first choice <strong>for</strong> treatment of epilepsy with generalized <strong>to</strong>nic-clonic<br />

seizures are<br />

– Pheny<strong>to</strong>in<br />

– Phenobarbital<br />

– Ethosuximide<br />

– Carbamazepine<br />

– All listed except ethosuximide<br />

232. Vinpocetin is effective in all cases except<br />

– Disturbance of movement in patients with trauma of extremities<br />

– Acute and chronic disturbances of cerebral blood circulation<br />

– Disturbances of memory after stroke<br />

– Cerebral atherosclerosis<br />

– Vertigo associated with disturbances of cerebral blood flow<br />

37


233. Opioid analgesics are used <strong>for</strong><br />

– Relief of pain associated with cancer<br />

– Acute pulmonary edema<br />

– Myocardial infarction<br />

– Neuroleptanalgesia<br />

– All listed<br />

234. The main pharmacological effect of anxiolytics is<br />

– Abolishing of panic and phobia<br />

– Abolishing of pain<br />

– Abolishing of depression<br />

– General anesthesia<br />

– Antipsychotic action<br />

235. Neuroleptics may be used <strong>for</strong> all except<br />

– Neuroleptanalgesia<br />

– Suppression of vomiting in cancer chemotherapy<br />

– Treatment of Parkinson's disease<br />

– Preanesthetic medication<br />

– Treatment of schizophrenia<br />

236. The main mechanism by which amitriptyline increases amount of<br />

catecholamines in CNS synapses is<br />

– Increase in catecholamines release from presynaptic membrane<br />

– Increase in catecholamines synthesis in presynaptic membrane<br />

– Prevention of catecholamines degradation in the synapse<br />

– Inhibition of neuronal re-uptake of catecholamines<br />

– Inhibition of MAO<br />

237. Type of recep<strong>to</strong>rs the most responsible <strong>for</strong> antipsychotic effect of neuroleptics<br />

is<br />

– 5-НТ recep<strong>to</strong>rs<br />

– Dopamine recep<strong>to</strong>rs<br />

– �-adrenorecep<strong>to</strong>rs<br />

– M-cholinorecep<strong>to</strong>rs<br />

– Histamine recep<strong>to</strong>rs<br />

238. Camphor is effective in the treatment of<br />

– Oppression of respiration caused by infections and in<strong>to</strong>xications<br />

– Collapse<br />

– Disturbances of memory after stroke<br />

– Pneumonia<br />

– Oppression of respiration, collapse, and pneumonia<br />

239. The drug of first choice <strong>for</strong> treatment of epilepsy with petit mal is<br />

– Pheny<strong>to</strong>in<br />

– Phenobarbital<br />

– Ethosuximide<br />

– Carbamazepine<br />

– Diazepam<br />

38


240. The followings is true concerning mechanism of anxiolytic effect of<br />

benzodiazepines and properties of their recep<strong>to</strong>rs<br />

– Drugs increase affinity of GABA <strong>to</strong> its recep<strong>to</strong>rs<br />

– Benzodiazepine recep<strong>to</strong>rs are directly coupled <strong>to</strong> Na +- channels<br />

– Benzodiazepine recep<strong>to</strong>rs activate G-proteins<br />

– Drugs cause depolarization<br />

– Benzodiazepine recep<strong>to</strong>r is a part of GABA-benzodiazepine recep<strong>to</strong>r-chloride channel<br />

complex<br />

241. Analeptic which has anti-inflammation and anti-allergy effects is<br />

– Nikethamide<br />

– Caffeine<br />

– Carbamazepine<br />

– Amphetamine<br />

– Aethimizolum<br />

242. Drugs <strong>for</strong> inhalation general anesthesia are all except<br />

– Thiopental-sodium<br />

– Ether <strong>for</strong> narcosis<br />

– Halotane<br />

– Nitrous oxide<br />

– Isoflurane<br />

243. Isoflurane is<br />

– Potent anesthetic<br />

– Volatile liquid<br />

– Non-irritant agent<br />

– Non-flammable<br />

– All listed<br />

244. Isoflurane may cause<br />

– Irritation of respira<strong>to</strong>ry pathways<br />

– Spasm of bronchi<br />

– Constriction of blood vessels<br />

– Increase in BP<br />

– Sensitization of heart <strong>to</strong> catecholamines<br />

245. Ether is not widely used now due <strong>to</strong><br />

– Irritation of respira<strong>to</strong>ry airways<br />

– Long-lasting and unpleasant induction in<strong>to</strong> anesthesia<br />

– Inflammable properties<br />

– Unpleasant recovery from anesthesia<br />

– All listed<br />

246. A patient has myocardial infarction. Inhalation general anesthetic <strong>for</strong> analgesia<br />

is<br />

– Thiopental-sodium<br />

– Ether <strong>for</strong> narcosis<br />

– Halotane<br />

– Nitrous oxide<br />

– Isoflurane<br />

39


247. Labor is accompanied by severe pain. Inhalation general anesthetic <strong>for</strong><br />

analgesia is<br />

– Thiopental-sodium<br />

– Ether <strong>for</strong> narcosis<br />

– Halotane<br />

– Nitrous oxide<br />

– Isoflurane<br />

248. Long-acting GABA-ergic IV anesthetic is<br />

– Thiopental-sodium<br />

– Ketamine<br />

– Sodium oxibutyrate<br />

– Propanididum<br />

– Propofol<br />

249. Barbiturate <strong>for</strong> IV general anesthesia is<br />

– Thiopental-sodium<br />

– Ketamine<br />

– Sodium oxibutyrate<br />

– Propanididum<br />

– Propofol<br />

250. All concerning IV general anesthetics is true except<br />

– Thiopental-sodium may cause oppression of respiration<br />

– Ketamine produces profound analgesia<br />

– Sodium oxibutyrate has antihypoxic properties<br />

– Propanididum acts during 3-5 min<br />

– IV general anesthetics are not used <strong>for</strong> induction <strong>to</strong> narcosis<br />

251. Ketamine is realized its action due <strong>to</strong><br />

– Barbiturate recep<strong>to</strong>rs<br />

– GABA-recep<strong>to</strong>rs<br />

– Binding <strong>to</strong> lipids of cell membranes<br />

– Dopamine recep<strong>to</strong>rs<br />

– Opiod recep<strong>to</strong>rs<br />

252. Sodium oxibutyrate is realized its action due <strong>to</strong><br />

– Barbiturate recep<strong>to</strong>rs<br />

– GABA-recep<strong>to</strong>rs<br />

– Binding <strong>to</strong> lipids of cell membranes<br />

– Dopamine recep<strong>to</strong>rs<br />

– Adrenergic recep<strong>to</strong>rs<br />

253. All concerning ethyl alcohol is true except<br />

– It is energy substrate<br />

– It has anti-shock action<br />

– It stimulates gastric secretion<br />

– It has antimicrobial action<br />

– It is used <strong>for</strong> general anesthesia<br />

254. Ethyl alcohol is used <strong>for</strong> processing of surgical area in concentration of<br />

– 90%<br />

40


– 70%<br />

– 40%<br />

– 20%<br />

– None of listed<br />

255. Ethyl alcohol is used <strong>for</strong> processing of surgical <strong>to</strong>ols in concentration of<br />

– 90%<br />

– 70%<br />

– 40%<br />

– 20%<br />

– None of listed<br />

256. To terminate vomiting of central genesis may be used all drugs except<br />

– Apomorphine<br />

– Chlorpromazine<br />

– Trifluoperazine<br />

– Metaclopromide<br />

– Diphenhydramine<br />

257. Ethyl alcohol is used <strong>for</strong> inhalation <strong>to</strong>gether with oxygen due <strong>to</strong><br />

– Antiseptic action<br />

– Anti-shock action<br />

– Irritating action<br />

– Neurotropic action<br />

– Antifoam action<br />

258. Selective inhibi<strong>to</strong>r of COX-2 is<br />

– Acetylsalicylic acid<br />

– Paracetamol<br />

– Metamizol<br />

– Indometacine<br />

– Meloxicam<br />

259. Drug <strong>for</strong> treatment of alcohol abuse is<br />

– Disulfirum (Teturam)<br />

– Naloxone<br />

– Unithiolum<br />

– Alloxim<br />

– Dithylinum<br />

260. Hypnotic with minimal disturbances in REM sleep is<br />

– Phenobarbital<br />

– Thiopental-sodium<br />

– Nitrazepam<br />

– Carbamazepine<br />

– Pheny<strong>to</strong>in<br />

261. Mechanism of phenobarbital’s action is connected with<br />

– Barbiturate recep<strong>to</strong>rs of Cl – channels<br />

– Benzdiazepine recep<strong>to</strong>rs of Cl – channels<br />

– Central M-cholinorecep<strong>to</strong>rs<br />

– Peripheral M-cholinorecep<strong>to</strong>rs<br />

41


– α2-adrenocep<strong>to</strong>rs<br />

262. Mechanism of action of diazepam is connected with<br />

– Barbiturate recep<strong>to</strong>rs of Cl – channels<br />

– Benzdiazepine recep<strong>to</strong>rs of Cl – channels<br />

– Central M-cholinorecep<strong>to</strong>rs<br />

– Peripheral M-cholinorecep<strong>to</strong>rs<br />

– α2-adrenocep<strong>to</strong>rs<br />

263. Anxiolytics are used in a clinic<br />

– For hypnotic action<br />

– For analgesic action<br />

– For antipsychotic action<br />

– For decrease in phobia<br />

– For decrease in depression<br />

264. Benzodiazepine used <strong>for</strong> termination of seizure attack is<br />

– Nitrazepam<br />

– Diazepam (Sibazonum)<br />

– Phenazepam<br />

– Medazepam<br />

– Chlordiazepoxide (Chlozepidum)<br />

265. Sodium bromide belongs <strong>to</strong> the group of<br />

– Anxiolytics<br />

– Neuroleptics<br />

– Sedatives<br />

– General anesthetics<br />

– Local anesthetics<br />

266. Indications <strong>to</strong> use of sodium bromide are all except<br />

– Neurastenia<br />

– Hysteria<br />

– Epilepsy<br />

– Insomnia<br />

– Acute psychosis<br />

267. Bromism is<br />

– Accumulation of bromides in the body<br />

– Acute poisoning with bromides<br />

– Therapeutic action of bromides<br />

– Scheme of treatment with bromides<br />

– None of above listed<br />

268. Tincture of valerian is used <strong>to</strong> treat of all except<br />

– Light <strong>for</strong>ms of neurosis<br />

– Insomnia caused by restlessness<br />

– Cardioneurosis<br />

– Spasms in the gut<br />

– Epilepsy<br />

269. Tincture of valerian belongs <strong>to</strong><br />

42


– Anxiolytics<br />

– Neuroleptics<br />

– Non-organic sedatives<br />

– Organic sedatives<br />

– Local anesthetics<br />

270. Neuroleptanalgesia is<br />

– Co-administration of neuroleptic and narcotic analgesic<br />

– Co-administration of neuroleptic and non-narcotic analgesic<br />

– Co-administration of local anesthetic and narcotic analgesic<br />

– Co-administration of anxiolytic and narcotic analgesic<br />

– Co-administration of inhalation and IV general anesthetics<br />

271. All preparations are neuroleptics except<br />

– Chlorpromazine<br />

– Trifluoprazine<br />

– Haloperidol<br />

– Chlorprothixene<br />

– Chlordiazepoxide<br />

272. The most suitable drug combination <strong>for</strong> neuroleptanalgesia is<br />

– Droperidol and fentanyl<br />

– Chlorpromazine and morphine<br />

– Haloperidol and pentazocine<br />

– Chlorpromazine and diphenhydramine (Dimedrolum)<br />

– Diphenhydramine (Dimedrolum) and Analginum<br />

273. Neuroleptics exert<br />

– Antipsychotic action<br />

– Anxiolytic action<br />

– Cataleptic action<br />

– Antiemetic action<br />

– All listed<br />

274. If the patient has schizophrenia accompanied by hallucinations and psychomo<strong>to</strong>r<br />

excitement, he must be treated with<br />

– Chlorpromazine (Aminazinum)<br />

– Diazepam<br />

– Tincture of valerian<br />

– Imipramine<br />

– Chlordiazepoxide<br />

275. If the patient has acute psychosis accompanied by hallucinations and agitation,<br />

he must be treated with<br />

– Haloperidol<br />

– Diazepam<br />

– Tincture of valerian<br />

– Imipramine<br />

– Chlordiazepoxide<br />

276. If the patient has severe vomiting caused by anticancer chemotherapy, he may<br />

be treated with<br />

43


– Trifluoperazine<br />

– Diazepam<br />

– Tincture of valerian<br />

– Imipramine<br />

– Chlordiazepoxide<br />

277. The patient has manic-depressive (bipolar) disease. Preparation of choice in<br />

this case is<br />

– Lithium carbonate<br />

– Diazepam<br />

– Chlorpromazine<br />

– Imipramine<br />

– Amitriptyline<br />

278. The patient has severe cancer pain. Analgesic <strong>for</strong> him is<br />

– Buprenorphine<br />

– Fentanyl<br />

– Naloxone<br />

– Metamizole<br />

– Acetylsalicylic acid<br />

279. The patient has traumatic shock. Analgesic <strong>for</strong> him is<br />

– Trimepiridine (Promedolum)<br />

– Phenylbutazone (Butadionum)<br />

– Naloxone<br />

– Metamizole<br />

– Acetylsalicylic acid<br />

280. The patient has trauma of brain. Narcotic analgesic contraindicated <strong>for</strong> him is<br />

– Morphine<br />

– Nitrous oxide<br />

– Sodium oxibutyrate<br />

– Metamizole<br />

– Acetaminophen (Paracetamol)<br />

281. Trimepiridine (Promedolum) is better in colic than morphine due <strong>to</strong><br />

– High analgesic activity<br />

– Minimal side-effects<br />

– Spasmolytic activity<br />

– Increase in uterus <strong>to</strong>ne<br />

– None of listed<br />

282. Trimepiridine (Promedolum) is used <strong>for</strong> analgesia in labor due <strong>to</strong><br />

– Analgesic activity<br />

– Minimal side-effects<br />

– Spasmolytic activity<br />

–Stimulation of uterus contractions<br />

– Both analgesic activity and stimulation of uterus contractions<br />

283. Acute poisoning with narcotic analgesics is diagnosed. Antagonist of opioid<br />

analgesics <strong>to</strong> treat this poisoning is<br />

– Trimepiridine<br />

44


– Phenylbutazone<br />

– Naloxone<br />

– Metamizole<br />

– Neostigmine<br />

284. The indications <strong>to</strong> aspirin use include<br />

– Headache<br />

– Toothache<br />

– Fever<br />

– Rheumatism<br />

– All listed<br />

285. Non-opioid analgesics may exert following side-effects except<br />

– Damage of gastric mucosa<br />

– Spasm of bronchi<br />

– Suppression of hemopoiesis<br />

– Drug dependence<br />

– Bleeding<br />

286. Only one non-narcotic analgesic is salicylate<br />

– Aspirin (Acetylsalicylic acid)<br />

– Phenylbutazone (Butadionum)<br />

– Metamizole (Analginum)<br />

– Paracetamol (Acethaminophen)<br />

– Indometacine<br />

287. Only one non-narcotic analgesic is para-aminophenol derivative<br />

– Aspirin (Acetylsalicylic acid)<br />

– Phenylbutazone (Butadionum)<br />

– Metamizole (Analginum)<br />

– Paracetamol (Acethaminophen)<br />

– Indometacine<br />

288. Non-narcotic analgesics from the group of pyrazolone derivatives are<br />

– Aspirin (Acetylsalicylic acid)<br />

– Phenylbutazone (Butadionum)<br />

– Metamizole (Analginum)<br />

– Paracetamol (Acethaminophen)<br />

– Both phenylbutazone (Butadionum) and metamizole (Analginum)<br />

289. Non-narcotic analgesics with strong anti-inflamma<strong>to</strong>ry action are all except<br />

– Indometacine<br />

– Phenylbutazone (Butadionum)<br />

– Ibuprofen<br />

– Paracetamol (Acethaminophen)<br />

– Pyroxicam<br />

290. Analgesic-antipyretic with weak anti-inflamma<strong>to</strong>ry action is<br />

– Indometacine<br />

– Phenylbutazone (Butadionum)<br />

– Ibuprofen<br />

– Paracetamol (Acethaminophen)<br />

45


– Pyroxicam<br />

291. Metamizole is not used <strong>for</strong><br />

– Headache<br />

– Toothache<br />

– Fever<br />

– Control of non-severe pos<strong>to</strong>perative pain<br />

– Collagenosis<br />

292. Metimazole may cause such side-effects as<br />

– Allergy<br />

– Agranulocy<strong>to</strong>sis<br />

– Gastric ulcer<br />

– Gastrointestinal bleeding<br />

– Both allergy and agranulocy<strong>to</strong>sis<br />

293. The patient has arthritis. Non-narcotic analgesics <strong>for</strong> his treatment are all<br />

except<br />

– Indometacine<br />

– Phenylbutazone (Butadionum)<br />

– Ibuprofen<br />

– Paracetamol (Acethaminophen)<br />

– Pyroxicam<br />

294. If the drug blocks COX and exerts anti-inflammation, anti-pyrexia and<br />

analgesia, it belongs <strong>to</strong><br />

– Opioid analgesics<br />

– Non-opioid analgesics<br />

– General anesthetics<br />

– Local anesthetics<br />

– Antihistamines<br />

295. If the drug binds <strong>to</strong> opioid recep<strong>to</strong>rs, exerts analgesia, and causes drug<br />

dependence, it belongs <strong>to</strong><br />

– Opioid analgesics<br />

– Non-opioid analgesics<br />

– General anesthetics<br />

– Local anesthetics<br />

– Antihistamines<br />

296. Imipramine causes antidepressant action due <strong>to</strong><br />

– Inhibition of MAO<br />

– Inhibition of monoamines reuptake<br />

– Blockage of α2-adrenocep<strong>to</strong>rs<br />

– Blockage of dopamine recep<strong>to</strong>rs<br />

– Blockage of central M-cholinergic recep<strong>to</strong>rs<br />

297. Nociception is<br />

– Pain perception in the organism<br />

– Limitation of pain in the organism<br />

– Limitation of pain by analgesics<br />

– Stimulation of non-specific resistance<br />

46


– All is false<br />

298. Anti-nocicep<strong>to</strong>in is represented by<br />

– Opioid recep<strong>to</strong>rs and their ligands<br />

– Adrenergic recep<strong>to</strong>rs and norepinephrine<br />

– Cholinergic recep<strong>to</strong>rs and acetylcholine<br />

– H-recep<strong>to</strong>rs and histamine<br />

– 5HT-recep<strong>to</strong>rs and sero<strong>to</strong>nin<br />

299. Mechanism of action of fluoxetine is<br />

– Non-selectine inhibition of monoamines re-uptake<br />

– Selectine inhibition of monoamines re-uptake<br />

– Non-selectine inhibition of MAO<br />

– Selectine inhibition of MAO<br />

– Stimulation of sero<strong>to</strong>nin synthesis<br />

300. Amphetamine causes all except<br />

– Strong stimulation of CNS<br />

– Euphoria<br />

– Drug dependence<br />

– Peripheral adrenomimetic action<br />

– Stimulation of appetite<br />

301. Caffeine is<br />

– Psychomo<strong>to</strong>r stimulant<br />

– Analeptic<br />

– Psychomo<strong>to</strong>r stimulant + analepic<br />

– Cognition enhancer<br />

– Antidepressant<br />

302. Indications <strong>to</strong> use of caffeine are all except<br />

– Hypotension<br />

– Collapse<br />

– Oppression of respiration<br />

– Asthenia<br />

– Psychomo<strong>to</strong>r excitement<br />

303. All concerning caffeine is true except<br />

– It is methylxanthine derivative<br />

– It has purinergic mechanism of action<br />

– It increases mental and physical per<strong>for</strong>mance<br />

– It has analeptic action<br />

– It has anxiolytic action<br />

304. Piracetam is<br />

– Cognition enhancer<br />

– Adrenergic psychomo<strong>to</strong>r stimulant<br />

– Purinergic psychomo<strong>to</strong>r stimulant<br />

– Direct-acting analeptic<br />

– Indirect-acting analeptic<br />

305. Correct in<strong>for</strong>mation concerning adap<strong>to</strong>gens is<br />

47


– They improve adaptation<br />

– They stimulate immunity<br />

– They increase physical and mental per<strong>for</strong>mance<br />

– They enhance low BP<br />

– All listed<br />

Situation tasks<br />

A teenager with a fracture of the hand was taken <strong>to</strong> the emergency room. To<br />

per<strong>for</strong>m reposition of fractured bones it was necessary <strong>to</strong> relax skeletal muscle. For this<br />

purpose myorelaxant causing depolarization of the post synaptic membrane was<br />

administered. Which of the following agents was used?<br />

A. Galantamine hydrobromide<br />

B. Mellictinum<br />

C. D-tubocurarine<br />

D. Succinylcholine (Dithylinum)<br />

E. Neostigmine (Proserinum)<br />

A patient with bronchial asthma addresses his doc<strong>to</strong>r with complaints about<br />

unpleasant palpitations that occur after usage of inhalation <strong>for</strong>m of isoprenaline<br />

(isadrinum). What is the cause of this side-effect?<br />

A. Stimulation of β1-adrenoceptros*<br />

B. Stimulation of β2-adrenoceptros<br />

C. Stimulation of α1-adrenoceptros<br />

D. Stimulation of α2-adrenoceptros<br />

E. Inhibition of M-chlolinorecep<strong>to</strong>rs<br />

Which of the following antiadrenergic drugs used in the treatment of hypertension is<br />

contraindicated in patients prone <strong>to</strong> bronchospasm?<br />

A. Prazosin<br />

B. Me<strong>to</strong>prolol<br />

C. Reserpine<br />

D. Atenolol<br />

E. Propranolol (Anaprilinum)<br />

To per<strong>for</strong>m fundoscopy ophthalmologist instilled in the eye an agent capable of<br />

causing mydriasis without cycloplegia. Point out this agent.<br />

A. Phenylephrine (Mesa<strong>to</strong>num)*<br />

B. Noradrenaline<br />

C. Atropine<br />

D. Pilocarpine<br />

E. Isoprenaline (Isadrinum)<br />

Administration of pirenzepine in patients with gastric peptic ulcer is not<br />

accompanied by numerous side-effects characteristic <strong>for</strong> atropine and other Mcholinoblckers<br />

due <strong>to</strong><br />

A. Inability <strong>to</strong> penetrate through blood brain barrier<br />

B. Selective inhibition of M1-cholinorecep<strong>to</strong>rs*<br />

C. Inhibition of all types of M-cholinorecep<strong>to</strong>rs<br />

D. Inhibition of cholinesterase<br />

E. Significant protein binding<br />

48


In complex treatment of a child, suffering from cerebral palsy, a doc<strong>to</strong>r decided <strong>to</strong><br />

include anticholinesterase drug modeately improving mental development. Choose this<br />

drug.<br />

A. Phosphacol<br />

B. Neostigmine (Proserinum)<br />

C. Galanthamine<br />

D. Pilocarpine<br />

E. Lobeline<br />

For testing refraction of eye atropine was instilled in<strong>to</strong> conjunctival sac. On<br />

completion of the procedure another cholinergic drug was used <strong>to</strong> counteract mydriasis<br />

and cycloplegia, caused by atropine. Point out this drug.<br />

A. Pilocarpine<br />

B. Lobeline<br />

C. Hyoscine (Scopolamine)<br />

D. Phenylephrine (Mesa<strong>to</strong>num)<br />

E. Pirenzepine<br />

A 43 year-old male patient is suffering from hypertension. His blood pressure was<br />

successfully <strong>control</strong>led by monotherapy with adrenoblocker. With time treatment was<br />

complicated with diarrhea and tachycardia. The patient addressed his doc<strong>to</strong>r and the drug<br />

was changed <strong>for</strong> another adrenoblocker. Which of adrenoblockers can cause above listed<br />

side-effects?<br />

A. Me<strong>to</strong>prolol<br />

B. Salbutamol<br />

C. Propranolol<br />

D. Dobutamine<br />

E. Prazosin<br />

A 5 years old child was taken <strong>to</strong> <strong>to</strong>xicological department with Belladonna<br />

poisoning. Alongside with peripheral manifestations the CNS symp<strong>to</strong>ms were manifested.<br />

Which of the following agents has <strong>to</strong> be administered as an antidote?<br />

A. Aceclidinum<br />

B. Pilocarpine<br />

C. Neostigmine (Proserinum)<br />

D. Adrenaline<br />

E. Galantamine hydrobromide<br />

After surgery per<strong>for</strong>med under general anesthesia with non-depolarizing<br />

myorelaxant spontaneous respiration was not res<strong>to</strong>red. Which of the following drugs is <strong>to</strong><br />

be used as an antidote of non-depolarizing myorelaxant?<br />

A. Aceclidinum<br />

B. Pilocarpin<br />

C. Neostigmine (Proserinum)<br />

D. Hyascine (Scopolamine)<br />

E. Isonitrosin<br />

After emotional stress a patient was permanently in a condition of nervous tension<br />

and had poor sleep. Doc<strong>to</strong>r prescribed him diazepam. Which of the listed effects of this<br />

drug is responsible <strong>for</strong> its clinical use?<br />

A. Hypotensive effect<br />

B. Analgesic effect<br />

49


C. Anticonvulsant<br />

D. Tranquilizing<br />

E. Anti psychotic<br />

A patient with <strong>to</strong>othache was relieving his pain with help of metamizole (Analginum).<br />

Point out another useful effect of this drug that contributes <strong>to</strong> the improvement of patient's<br />

condition<br />

A. Sedative effect<br />

B. Anti-inflamma<strong>to</strong>ry effect<br />

C. Antl-platelet effect<br />

D. Antioxidative effect<br />

E. Antimicrobial effect<br />

A patient with poisoning caused by carbon monoxide was administered directly<br />

acting analeptic drug. What medicine was used?<br />

A. Codeine<br />

B. Ephedrine<br />

C. Caffeine<br />

D. Atropine sulfate<br />

E. Lobeline<br />

A premature newborn was apnoic. Directly acting analeptic drug was given <strong>to</strong><br />

res<strong>to</strong>re breathing. What medicine was most probably administered <strong>to</strong> the patient?<br />

A. Aethimisolum<br />

B. Phenylephrine (Mesa<strong>to</strong>num)<br />

C. Adrenaline<br />

D. Atropine<br />

E. Lobeline<br />

A 60 year-old woman addressed her doc<strong>to</strong>r complaining of side-effects, which<br />

appeared while treatment with chlorpromazine (aminazinum). She was troubled with<br />

tremor and disturbances of movements. What is the mechanism of these side-effects?<br />

A. Activation of hyppocampus<br />

B. Inhibition of reticular <strong>for</strong>mation (�1-adrenocep<strong>to</strong>rs)<br />

C. Inhibition of neostriatum (D2 recep<strong>to</strong>rs)<br />

D. Inhibition of hypothalamus<br />

E. Inhibition of hyppocampus<br />

A 50 years old patient with chronic alcoholism became aggressive. To abolish<br />

aggression, chlorpromazine was administered intramuscularly. The patient's attempt <strong>to</strong><br />

rise soon after an injection resulted in loss of consciousness. What is the probable cause<br />

of such complication?<br />

A. Blockade of reticular <strong>for</strong>mation<br />

B. Disturbance of coronary blood circulation<br />

C. Blockade of �-adrenocep<strong>to</strong>rs<br />

D. Inhibition of hypothamus<br />

E. Blockade of M-cholinocep<strong>to</strong>rs<br />

A patient was permanently in a condition of nervous tension and had poor sleep.<br />

Doc<strong>to</strong>r prescribed him phenazepam. Which of the listed mechanisms of action provides<br />

anxiolytic effect of this drug?<br />

A. Blockage of �2-adrenocep<strong>to</strong>rs<br />

50


B. Blockage of dopamin recep<strong>to</strong>rs<br />

C. Stimulation of barbiturate recep<strong>to</strong>rs<br />

D. Stimulation of benzdiazepine recep<strong>to</strong>rs<br />

E. Stimulation of NMDA recep<strong>to</strong>rs<br />

A 60-year-old male is brought <strong>to</strong> emergency room. He is coma<strong>to</strong>se and his pupils<br />

are constricted. Physician suspects opium overdose. What is the best drug <strong>to</strong> be<br />

administered?<br />

A. Flumazanil<br />

B. Calcium carbonate<br />

C. Sodium bicarbonate<br />

D. Naloxone<br />

E. Atropine<br />

A patient had a stroke. Which of the listed drugs is necessary <strong>to</strong> include in the<br />

complex therapy in order <strong>to</strong> improve mental per<strong>for</strong>mance?<br />

A. Caffeine<br />

B. Piracetam<br />

C. Diazepam<br />

D. Phenazepam<br />

E. Amitiptyline<br />

A 20-year-old male is brought <strong>to</strong> emergency room in coma<strong>to</strong>se state. The overdose<br />

of benzdiazepins is diagnosed. What is the best drug <strong>to</strong> be administered?<br />

A. Flumazanil<br />

B. Atropine<br />

C. Sodium bicarbonate<br />

D. Naloxone<br />

E. Naltrexone<br />

51

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!